Reactive	O
oxygen	O
intermediates	O
activate	O
NF-kappa	B-protein
B	I-protein
in	O
a	O
tyrosine	O
kinase-dependent	O
mechanism	O
and	O
in	O
combination	O
with	O
vanadate	O
activate	O
the	O
p56lck	B-protein
and	I-protein
p59fyn	I-protein
tyrosine	I-protein
kinases	I-protein
in	O
human	B-cell_type
lymphocytes	I-cell_type
.	O

We	O
have	O
previously	O
observed	O
that	O
ionizing	O
radiation	O
induces	O
tyrosine	O
phosphorylation	O
in	O
human	B-cell_type
B-lymphocyte	I-cell_type
precursors	I-cell_type
by	O
stimulation	O
of	O
unidentified	O
tyrosine	B-protein
kinases	I-protein
and	O
this	O
phosphorylation	O
is	O
substantially	O
augmented	O
by	O
vanadate	O
.	O

Ionizing	O
radiation	O
generates	O
reactive	O
oxygen	O
intermediates	O
(	O
ROI	O
)	O
.	O

Because	O
H2O2	O
is	O
a	O
potent	O
ROI	O
generator	O
that	O
readily	O
crosses	O
the	O
plasma	O
membrane	O
,	O
we	O
used	O
H2O2	O
to	O
examine	O
the	O
effects	O
of	O
ROI	O
on	O
signal	O
transduction	O
.	O

We	O
now	O
provide	O
evidence	O
that	O
the	O
tyrosine	O
kinase	O
inhibitor	O
herbimycin	O
A	O
and	O
the	O
free	O
radical	O
scavenger	O
N-acetyl-cysteine	O
inhibit	O
both	O
radiation-induced	O
and	O
H2O2-induced	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
indicating	O
that	O
activation	O
triggered	O
by	O
ROI	O
is	O
dependent	O
on	O
tyrosine	O
kinase	O
activity	O
.	O

H2O2	O
was	O
found	O
to	O
stimulate	O
Ins-1	B-protein
,	I-protein
4	I-protein
,	I-protein
5-P3	I-protein
production	O
in	O
a	O
tyrosine	O
kinase-dependent	O
manner	O
and	O
to	O
induce	O
calcium	O
signals	O
that	O
were	O
greatly	O
augmented	O
by	O
vanadate	O
.	O

The	O
synergistic	O
induction	O
of	O
tyrosine	O
phosphorylation	O
by	O
H2O2	O
plus	O
vanadate	O
included	O
physiologically	O
relevant	O
proteins	O
such	O
as	O
PLC	B-protein
gamma	I-protein
1	I-protein
.	O

Although	O
treatment	O
of	O
cells	O
with	O
H2O2	O
alone	O
did	O
not	O
affect	O
the	O
activity	O
of	O
src	B-protein
family	I-protein
kinases	I-protein
,	O
treatment	O
with	O
H2O2	O
plus	O
vanadate	O
led	O
to	O
activation	O
of	O
the	O
p56lck	B-protein
and	I-protein
p59fyn	I-protein
tyrosine	I-protein
kinases	I-protein
.	O

The	O
combined	O
inhibition	O
of	O
phosphatases	B-protein
and	O
activation	O
of	O
kinases	B-protein
provides	O
a	O
potent	O
mechanism	O
for	O
the	O
synergistic	O
effects	O
of	O
H2O2	O
plus	O
vanadate	O
.	O

Induction	O
of	O
tyrosine	O
phosphorylation	O
by	O
ROI	O
may	O
thus	O
lead	O
to	O
many	O
of	O
the	O
pleiotropic	O
effects	O
of	O
ROI	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
,	O
including	O
downstream	O
activation	O
of	O
PLC	B-protein
gamma	I-protein
1	I-protein
and	O
NF-kappa	B-protein
B	I-protein

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Reactive	NULL
Oxygen	NULL
Intermediates	NULL
Activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
a	NULL
Tyrosine	NULL
Kinase-Dependent	NULL
Mechanism	NULL
and	NULL
in	NULL
Combination	NULL
With	NULL
Vanadate	NULL
Activate	NULL
the	NULL
p56	NULL
``	NULL
*	NULL
and	NULL
p59	NULL
``	NULL
Tyrosine	NULL
Kinases	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
By	NULL
Gary	NULL
L.	NULL
Schieven	NULL
,	NULL
Jean	NULL
M.	NULL
Kirihara	NULL
,	NULL
Dorothea	NULL
E.	NULL
Myers	NULL
,	NULL
Jeffrey	NULL
A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
Fatih	NULL
M.	NULL
Uckun	NULL
We	NULL
have	NULL
previously	NULL
observed	NULL
that	NULL
ionizing	NULL
radiation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
by	NULL
stimulation	NULL
of	NULL
unidentified	NULL
tyrosine	NULL
kinases	NULL
and	NULL
this	NULL
phosphorylation	NULL
is	NULL
substantially	NULL
augmented	NULL
by	NULL
vanadate	NULL
.	NULL

lonizing	NULL
radiation	NULL
generates	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROQ1	NULL
)	NULL
.	NULL

Because	NULL
H	NULL
;	NULL
,0	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
ROI	NULL
generator	NULL
that	NULL
readily	NULL
crosses	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
we	NULL
used	NULL
H	NULL
,	NULL
O	NULL
,	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
ROI	NULL
on	NULL
signal	NULL
transduction	NULL
.	NULL

We	NULL
now	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
and	NULL
the	NULL
free	NULL
radical	NULL
scavenger	NULL
N-acetyl-cys-teine	NULL
inhibit	NULL
both	NULL
radiation-induced	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
indicating	NULL
that	NULL
activation	NULL
triggered	NULL
by	NULL
ROI	NULL
is	NULL
dependent	NULL
on	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
was	NULL
found	NULL
to	NULL
stimulate	NULL
ins-1,4,5-P	NULL
;	NULL
production	NULL
in	NULL
a	NULL
tyrosine	NULL
kinase	NULL
EACTIVE	NULL
OXYGEN	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
clinical	NULL
conditions	NULL
,	NULL
includ-	NULL
ing	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
other	NULL
autoimmune	NULL
diseases	NULL
,	NULL
as	NULL
well	NULL
as	NULL
radiation	NULL
injury	NULL
.	NULL
``	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
inducible	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
series	NULL
of	NULL
target	NULL
genes	NULL
.	NULL
``	NULL

A	NULL
large	NULL
number	NULL
of	NULL
agents	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
including	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
,	NULL
mi-togens	NULL
,	NULL
calcium	NULL
ionophores	NULL
,	NULL
and	NULL
viruses	NULL
(	NULL
by	NULL
the	NULL
action	NULL
of	NULL
viral	NULL
transactivator	NULL
proteins	NULL
or	NULL
double-stranded	NULL
RNA	NULL
inter-mediates	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
«	NULL
B	NULL
elements	NULL
in	NULL
regulatory	NULL
domains	NULL
of	NULL
target	NULL
genes	NULL
serve	NULL
as	NULL
response	NULL
elements	NULL
for	NULL
oxidant	NULL
stress	NULL
triggered	NULL
by	NULL
ROI	NULL
.	NULL

Extensive	NULL
studies	NULL
by	NULL
Schreck	NULL
et	NULL
al	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
mouse	NULL
fibroblasts	NULL
,	NULL
and	NULL
mouse	NULL
pre-B	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
interleukin-1	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
lipopolysaccharide	NULL
,	NULL
lectin	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
calcium	NULL
ionophores	NULL
,	NULL
or	NULL
cycloheximide	NULL
is	NULL
dependent	NULL
on	NULL
ROI	NULL
and	NULL
can	NULL
therefore	NULL
be	NULL
effectively	NULL
inhibited	NULL
by	NULL
the	NULL
radical	NULL
scavengers	NULL
N-acetyl-L-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
and	NULL
PDTC	NULL
(	NULL
a	NULL
pyrrolidone	NULL
derivative	NULL
of	NULL
dithiocarbamate	NULL
)	NULL
.	NULL

Ionizing	NULL
radiation	NULL
causes	NULL
radioly-	NULL
From	NULL
the	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
;	NULL
and	NULL
the	NULL
Tumor	NULL
Immunology	NULL
Laboratory	NULL
,	NULL
Section	NULL
of	NULL
Cancer	NULL
and	NULL
Leukemia	NULL
Biology	NULL
,	NULL
Department	NULL
of	NULL
Therapeutic	NULL
Radi-ology-Radiation	NULL
Oncology	NULL
,	NULL
and	NULL
the	NULL
Bone	NULL
Marrow	NULL
Transplant	NULL
Pro-gram	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Minneapo-lis	NULL
,	NULL
MN	NULL
.	NULL

Submitted	NULL
August	NULL
19	NULL
,	NULL
1992	NULL
;	NULL
accepted	NULL
April	NULL
14	NULL
,	NULL
1993	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Bristol-Myers	NULL
Squibb	NULL
and	NULL
in	NULL
part	NULL
by	NULL
US	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
No	NULL
.	NULL

R29	NULL
CA-42111	NULL
,	NULL
RO1	NULL
CA-42633	NULL
,	NULL
and	NULL
RO1	NULL
CA-51425	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
DHHS	NULL
.	NULL

F.M.U	NULL
.	NULL

is	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

This	NULL
is	NULL
publication	NULL
no	NULL
.	NULL

91	NULL
from	NULL
the	NULL
Tumor	NULL
Immunology	NULL
Laboratory	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Gary	NULL
L.	NULL
Schieven	NULL
,	NULL
PhD	NULL
,	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institue	NULL
,	NULL
3005	NULL
First	NULL
Ave	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98121	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/93/8204-0031	NULL
$	NULL
3.00/0	NULL
1212	NULL
dependent	NULL
manner	NULL
and	NULL
to	NULL
induce	NULL
calcium	NULL
signals	NULL
that	NULL
were	NULL
greatly	NULL
augmented	NULL
by	NULL
vanadate	NULL
.	NULL

The	NULL
synergistic	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
included	NULL
physiologically	NULL
relevant	NULL
proteins	NULL
such	NULL
as	NULL
PLCy1	NULL
.	NULL

Although	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
alone	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
src	NULL
family	NULL
kinases	NULL
,	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
p56	NULL
``	NULL
and	NULL
p59Y	NULL
``	NULL
tyrosine	NULL
kinases	NULL
.	NULL

The	NULL
combined	NULL
inhibition	NULL
of	NULL
phosphatases	NULL
and	NULL
activation	NULL
of	NULL
kinases	NULL
provides	NULL
a	NULL
potent	NULL
mechanism	NULL
for	NULL
the	NULL
synergistic	NULL
effects	NULL
of	NULL
H,0	NULL
,	NULL
;	NULL
plus	NULL
vanadate	NULL
.	NULL

Induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
ROI	NULL
may	NULL
thus	NULL
lead	NULL
to	NULL
many	NULL
of	NULL
the	NULL
pleiotropic	NULL
effects	NULL
of	NULL
ROI	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
including	NULL
downstream	NULL
activation	NULL
of	NULL
PLCy1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

sis	NULL
of	NULL
bound	NULL
and	NULL
solvent	NULL
water	NULL
in	NULL
the	NULL
cell	NULL
producing	NULL
OH	NULL
radicals	NULL
,	NULL
hydrated	NULL
electrons	NULL
,	NULL
and	NULL
H,0	NULL
,	NULL
.	NULL

Additional	NULL
H	NULL
,	NULL
O	NULL
;	NULL
is	NULL
generated	NULL
in	NULL
irradiated	NULL
cells	NULL
by	NULL
the	NULL
dismutation	NULL
of	NULL
superoxide	NULL
anions	NULL
that	NULL
are	NULL
produced	NULL
by	NULL
the	NULL
action	NULL
of	NULL
hydrated	NULL
electrons	NULL
on	NULL
oxygen	NULL
molecules	NULL
.	NULL

*	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
be	NULL
converted	NULL
into	NULL
highly	NULL
active	NULL
ROL	NULL
'	NULL
Compelling	NULL
evidence	NULL
indicates	NULL
that	NULL
a	NULL
cascade	NULL
of	NULL
cytoplasmic	NULL
events	NULL
is	NULL
initiated	NULL
when	NULL
cells	NULL
are	NULL
irra-diated	NULL
,	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B°	NULL
and	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
-dependent	NULL
induction	NULL
of	NULL
c-jun	NULL
expression	NULL
.	NULL

*	NULL
``	NULL
Tyrosine	NULL
phosphorylation	NULL
is	NULL
an	NULL
early	NULL
response	NULL
to	NULL
stimulation	NULL
via	NULL
slg	NULL
in	NULL
B	NULL
lymphocytes®	NULL
and	NULL
via	NULL
CD3/Ti	NULL
and	NULL
accessory	NULL
molecules	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

Tyrosine	NULL
phosphorylation	NULL
is	NULL
essential	NULL
for	NULL
both	NULL
T-cell	NULL
``	NULL
and	NULL
B-cell	NULL
``	NULL
activation	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
use	NULL
of	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
.	NULL

The	NULL
src	NULL
family	NULL
tyrosine	NULL
kinases	NULL
have	NULL
been	NULL
found	NULL
to	NULL
play	NULL
key	NULL
roles	NULL
in	NULL
this	NULL
signal	NULL
transduction	NULL
process	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

'*'*	NULL
We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
ionizing	NULL
radiation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
by	NULL
stimulation	NULL
of	NULL
unidentified	NULL
tyrosine-specific	NULL
protein	NULL
kinases	NULL
.	NULL
``	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
ionizing	NULL
radiation	NULL
was	NULL
greatly	NULL
increased	NULL
when	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
vanadate	NULL
.	NULL
``	NULL

More	NULL
recently	NULL
,	NULL
we	NULL
observed	NULL
in	NULL
human	NULL
lymphocyte	NULL
precursors	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
irradiation	NULL
with	NULL
y-rays	NULL
is	NULL
abrogated	NULL
by	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
an	NULL
important	NULL
and	NULL
mandatory	NULL
proximal	NULL
step	NULL
in	NULL
the	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
ionizing	NULL
radiation	NULL
triggers	NULL
tyrosine	NULL
kinases	NULL
and	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
is	NULL
as	NULL
yet	NULL
unknown	NULL
.	NULL

The	NULL
present	NULL
study	NULL
provides	NULL
evidence	NULL
that	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
triggered	NULL
by	NULL
ROI	NULL
.	NULL

We	NULL
also	NULL
report	NULL
that	NULL
the	NULL
synergistic	NULL
effects	NULL
of	NULL
ROI	NULL
and	NULL
vanadate	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
are	NULL
due	NULL
to	NULL
kinase	NULL
activation	NULL
in	NULL
addition	NULL
to	NULL
phosphatase	NULL
inhibition	NULL
,	NULL
leading	NULL
to	NULL
phosphorylation	NULL
of	NULL
physiologically	NULL
relevant	NULL
substrates	NULL
and	NULL
downstream	NULL
signaling	NULL
events	NULL
such	NULL
as	NULL
calcium	NULL
mobilization	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

-	NULL
In	NULL
our	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
the	NULL
pre-pre-B-cell	NULL
line	NULL
REH	NULL
,	NULL
pre-B-cell	NULL
line	NULL
NALM-6	NULL
,	NULL
the	NULL
early	NULL
B/Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
Daudi	NULL
and	NULL
Ramos	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
CD3*	NULL
subclone	NULL
(	NULL
CEM.6	NULL
)	NULL
``	NULL
``	NULL
of	NULL
the	NULL
Blood	NULL
,	NULL
Vol	NULL
82	NULL
,	NULL
No	NULL
4	NULL
(	NULL
August	NULL
15	NULL
)	NULL
,	NULL
1993	NULL
:	NULL
pp	NULL
1212-1220	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATE	NULL
INDUCED	NULL
SIGNALS	NULL
pre-T-cell	NULL
line	NULL
CEM	NULL
.	NULL

The	NULL
radiation	NULL
sensitivity	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
was	NULL
detailed	NULL
in	NULL
a	NULL
previous	NULL
report	NULL
.	NULL

``	NULL
*	NULL
Irradiation	NULL
and	NULL
treatments	NULL
of	NULL
cells	NULL
.	NULL

-	NULL
Cells	NULL
(	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/mL	NULL
)	NULL
in	NULL
plastic	NULL
tissue	NULL
culture	NULL
flasks	NULL
were	NULL
irradiated	NULL
with	NULL
500	NULL
to	NULL
2,000	NULL
cGy	NULL
at	NULL
a	NULL
dose	NULL
rate	NULL
of	NULL
100	NULL
cGy/min	NULL
during	NULL
log	NULL
phase	NULL
and	NULL
under	NULL
aerobic	NULL
conditions	NULL
using	NULL
a	NULL
``	NULL
Cs	NULL
irradiator	NULL
(	NULL
Model	NULL
Mark	NULL
I	NULL
;	NULL
JL	NULL
Shephard	NULL
and	NULL
Assoc	NULL
,	NULL
Glendale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
3	NULL
to	NULL
9	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
MO	NULL
)	NULL
,	NULL
100	NULL
amol/L	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
Fisher	NULL
Scientific	NULL
,	NULL
Pittsburgh	NULL
,	NULL
PA	NULL
)	NULL
,	NULL
or	NULL
both	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

For	NULL
experiments	NULL
involving	NULL
the	NULL
use	NULL
of	NULL
kinase	NULL
inhibitors	NULL
before	NULL
irradiation	NULL
or	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
37°C	NULL
with	NULL
(	NULL
1	NULL
)	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
(	NULL
2	NULL
)	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
genistein	NULL
(	NULL
370	NULL
umol/	NULL
L	NULL
;	NULL
ICN	NULL
Biomedical	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
(	NULL
3	NULL
)	NULL
the	NULL
PKC	NULL
inhibitor	NULL
1-	NULL
(	NULL
5-isoquinolinylsufonyl	NULL
)	NULL
-2-methylpiperazine	NULL
(	NULL
30	NULL
umo	NULL
!	NULL

l/L	NULL
H7	NULL
;	NULL
GIBCO-BRL	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
or	NULL
for	NULL
24	NULL
hours	NULL
at	NULL
37°C	NULL
with	NULL
(	NULL
4	NULL
)	NULL
the	NULL
potent	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
(	NULL
12	NULL
umol/L	NULL
;	NULL
GIBCO-BRL	NULL
)	NULL
,	NULL
using	NULL
previously	NULL
described	NULL
protocols	NULL
.	NULL
``	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
20	NULL
mmol/L	NULL
NAC	NULL
for	NULL
1	NULL
hour	NULL
according	NULL
to	NULL
the	NULL
treatment	NULL
protocol	NULL
reported	NULL
by	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

>	NULL
For	NULL
the	NULL
measurement	NULL
of	NULL
[	NULL
Ca*1i	NULL
,	NULL
cells	NULL
were	NULL
used	NULL
immediately	NULL
after	NULL
addition	NULL
of	NULL
stimulating	NULL
agents	NULL
.	NULL

For	NULL
IgM	NULL
cross-linking	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ug/mL	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragment	NULL
goat	NULL
antihuman	NULL
IgM	NULL
(	NULL
Jack-son	NULL
ImmunoResearch	NULL
Labs	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD3	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
CD4	NULL
was	NULL
achieved	NULL
by	NULL
the	NULL
use	NULL
of	NULL
biotinylated	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
against	NULL
CD3	NULL
(	NULL
G19-4	NULL
)	NULL
and	NULL
CD4	NULL
(	NULL
G17-2	NULL
)	NULL
followed	NULL
by	NULL
treatment	NULL
with	NULL
avidin	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Nuclear	NULL
-	NULL
extraction	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

-	NULL
Four	NULL
hours	NULL
after	NULL
radiation	NULL
or	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
,	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
according	NULL
to	NULL
previously	NULL
published	NULL
proce-dures	NULL
.	NULL
``	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Fifty-nanogram	NULL
amounts	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
tandem	NULL
repeat	NULL
of	NULL
the	NULL
1	NULL
1-bp	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
GGGGACTTTCC	NULL
;	NULL
obtained	NULL
in	NULL
kit	NULL
form	NULL
from	NULL
GIBCO-BRL	NULL
)	NULL
were	NULL
end-labeled	NULL
using	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
according	NULL
to	NULL
the	NULL
recommendations	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

One	NULL
nanogram	NULL
of	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
(	NULL
400,000	NULL
cpm	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
10	NULL
ug	NULL
nuclear	NULL
protein	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
25	NULL
mmol/L	NULL
TrisHCL	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
1	NULL
ug	NULL
poly	NULL
dI/dC	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
5	NULL
mmol/	NULL
L	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
0.5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
and	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
.	NULL

Competition	NULL
studies	NULL
with	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
were	NULL
performed	NULL
by	NULL
preincubating	NULL
the	NULL
nuclear	NULL
protein	NULL
for	NULL
15	NULL
minutes	NULL
on	NULL
ice	NULL
with	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
*°P	NULL
end-labeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

Controls	NULL
used	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
and	NULL
NF-1	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
competition	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
were	NULL
analyzed	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
using	NULL
a	NULL
4.5	NULL
%	NULL
running	NULL
gel	NULL
under	NULL
nondenaturing	NULL
conditions	NULL
,	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
buffer	NULL
(	NULL
25	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
8.2	NULL
,	NULL
22.5	NULL
mmol/L	NULL
borate	NULL
,	NULL
0.25	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
gets	NULL
were	NULL
pre-run	NULL
at	NULL
150	NULL
V	NULL
for	NULL
2	NULL
hours	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
samples	NULL
were	NULL
loaded	NULL
and	NULL
electrophoresed	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
hours	NULL
at	NULL
150	NULL
V.	NULL
Gels	NULL
were	NULL
dried	NULL
overnight	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
5	NULL
X-ray	NULL
film	NULL
using	NULL
intensifying	NULL
screens	NULL
at	NULL
-70°C	NULL
.	NULL

Immunoprecipitations	NULL
,	NULL
immunoblots	NULL
,	NULL
and	NULL
kinase	NULL
assays	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
lysed	NULL
on	NULL
ice	NULL
with	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
100	NULL
amol/L	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
100	NULL
«	NULL
mol/L	NULL
sodium	NULL
molybdate	NULL
,	NULL
8	NULL
g/mL	NULL
aprotinin	NULL
,	NULL
5	NULL
ug/mL	NULL
leu-peptin	NULL
,	NULL
500	NULL
umol/L	NULL
phenyImethysulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
13,000g	NULL
to	NULL
remove	NULL
insoluble	NULL
material	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
PLCy1	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Immunoprecipitation	NULL
of	NULL
ras	NULL
GT	NULL
Pase-activating	NULL
protein	NULL
(	NULL
GAP	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
rabbit	NULL
antisera	NULL
to	NULL
human	NULL
GAP	NULL
(	NULL
Upstate	NULL
Biotechnol-ogy	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
immunoprecipitation	NULL
of	NULL
p34	NULL
``	NULL
was	NULL
1213	NULL
performed	NULL
with	NULL
an	NULL
MoAb	NULL
to	NULL
human	NULL
p34	NULL
``	NULL
(	NULL
Upstate	NULL
Biotechnol-ogy	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
the	NULL
{	NULL
chain	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
was	NULL
performed	NULL
using	NULL
anti-	NULL
{	NULL
antibody	NULL
kindly	NULL
provided	NULL
by	NULL
J.	NULL
Sancho	NULL
and	NULL
C.	NULL
Terhorst	NULL
(	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL
``	NULL

Immune	NULL
complexes	NULL
were	NULL
collected	NULL
on	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Repligen	NULL
,	NULL
Cambridge	NULL
MA	NULL
)	NULL
,	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
and	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
sodium	NULL
dodecyl	NULL
sulfate-poly-acrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
followed	NULL
by	NULL
immunoblotting	NULL
.	NULL

Immunoblots	NULL
with	NULL
anti-PLCy1	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Antiphosphotyrosine	NULL
immunoblotting	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
,	NULL
``	NULL
using	NULL
affinity-purified	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
.	NULL
``	NULL

Immune	NULL
complex	NULL
tyrosine	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
exogenous	NULL
substrate	NULL
enolase	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Samples	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antisera	NULL
prepared	NULL
against	NULL
unique	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
src	NULL
family	NULL
tyrosine	NULL
kinases	NULL
,	NULL
``	NULL
``	NULL
which	NULL
were	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
Joseph	NULL
Bolen	NULL
(	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
[	NULL
Ca	NULL
``	NULL
*	NULL
]	NULL
and	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
(	NULL
Ins-1,4,5-P	NULL
;	NULL
)	NULL
.	NULL

_	NULL
[	NULL
Ca®*1i	NULL
responses	NULL
were	NULL
measured	NULL
using	NULL
indo-1	NULL
(	NULL
Molecu-lar	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
and	NULL
a	NULL
model	NULL
50HH/2150	NULL
flow	NULL
cytometer	NULL
(	NULL
Ortho	NULL
,	NULL
Westwood	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

*	NULL
``	NULL
The	NULL
histograms	NULL
were	NULL
analyzed	NULL
by	NULL
programs	NULL
that	NULL
calculate	NULL
the	NULL
mean	NULL
indo-1	NULL
violet/	NULL
blue	NULL
fluorescence	NULL
ratio	NULL
versus	NULL
time	NULL
.	NULL

There	NULL
are	NULL
100	NULL
data	NULL
points	NULL
on	NULL
the	NULL
X	NULL
(	NULL
time	NULL
)	NULL
axis	NULL
of	NULL
all	NULL
flow	NULL
cytometric	NULL
data	NULL
.	NULL

Ins-1,4,5-P	NULL
,	NULL
levels	NULL
were	NULL
measured	NULL
using	NULL
a	NULL
highly	NULL
specific	NULL
D-myo-inositol	NULL
1,4,5-	NULL
{	NULL
°H	NULL
}	NULL
-trisphosphate	NULL
assay	NULL
system	NULL
(	NULL
Amersham	NULL
Corp	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

This	NULL
assay	NULL
is	NULL
based	NULL
on	NULL
the	NULL
competition	NULL
between	NULL
unlabeled	NULL
Ins-1,4,5-P	NULL
;	NULL
and	NULL
a	NULL
fixed	NULL
quantity	NULL
of	NULL
a	NULL
high	NULL
specific	NULL
activity	NULL
tritiated	NULL
Ins-1,4,5-P	NULL
;	NULL
tracer	NULL
(	NULL
°H-Ins-1,4,5-P	NULL
;	NULL
)	NULL
for	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
binding	NULL
sites	NULL
on	NULL
a	NULL
specific	NULL
and	NULL
sensitive	NULL
bovine	NULL
adrenal	NULL
binding	NULL
protein	NULL
preparation	NULL
.	NULL

RESULTS	NULL
The	NULL
role	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
in	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

We	NULL
used	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
ROI-scavenger	NULL
NAC	NULL
and	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
on	NULL
(	NULL
1	NULL
)	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
(	NULL
2	NULL
)	NULL
ROT-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Ramos	NULL
and	NULL
Daudi	NULL
cells	NULL
.	NULL

After	NULL
passive	NULL
diffusion	NULL
through	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
can	NULL
be	NULL
converted	NULL
into	NULL
highly	NULL
reactive	NULL
ROI	NULL
such	NULL
as	NULL
the	NULL
superoxide	NULL
anion	NULL
and	NULL
the	NULL
hydroxyl	NULL
radical	NULL
.	NULL

!	NULL

Therefore	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
was	NULL
used	NULL
as	NULL
a	NULL
potent	NULL
ROI	NULL
generator	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
ROI	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Doses	NULL
of	NULL
radiation	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
were	NULL
chosen	NULL
so	NULL
as	NULL
to	NULL
show	NULL
that	NULL
strong	NULL
signals	NULL
could	NULL
be	NULL
clearly	NULL
inhibited	NULL
by	NULL
NAC	NULL
and	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
.	NULL

The	NULL
doses	NULL
used	NULL
were	NULL
based	NULL
on	NULL
previous	NULL
reports	NULL
that	NULL
established	NULL
optimum	NULL
doses	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
``	NULL
and	NULL
radiation*	NULL
``	NULL
for	NULL
such	NULL
signals	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
poly	NULL
dI-dC	NULL
was	NULL
used	NULL
to	NULL
eliminate	NULL
nonspecific	NULL
binding	NULL
.	NULL

Notably	NULL
,	NULL
ionizing	NULL
radiation	NULL
with	NULL
500	NULL
to	NULL
2,000	NULL
cGy	NULL
y-rays	NULL
stimulated	NULL
a	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
as	NULL
reflected	NULL
by	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
intensity	NULL
of	NULL
a	NULL
shifted	NULL
band	NULL
that	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Ramos	NULL
cells	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

This	NULL
retarded	NULL
band	NULL
was	NULL
eliminated	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
,	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
DNA-protein	NULL
interactions	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-1	NULL
control	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
to	NULL
the	NULL
retarded	NULL
band	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
genistein	NULL
and	NULL
herbimycin	NULL
markedly	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
in	NULL
accordance	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1214	NULL
¢	NULL
@	NULL
¢	NULL
®	NULL
o	NULL
o	NULL
#	NULL
$	NULL
A	NULL
@	NULL
&	NULL
°	NULL
&	NULL
¢	NULL
&	NULL
#	NULL
5	NULL
&	NULL
8	NULL
``	NULL
&	NULL
a	NULL
a~	NULL
3	NULL
R	NULL
»	NULL
ra	NULL
s	NULL
a	NULL
o	NULL
o	NULL
o	NULL
$	NULL
o	NULL
o	NULL
o	NULL
$	NULL
YC	NULL
_	NULL
$	NULL
a	NULL
'	NULL
o	NULL
$	NULL
@	NULL
$	NULL
P	NULL
#	NULL
$	NULL
#	NULL
’	NULL
“	NULL
U	NULL
t	NULL
®	NULL
ﬂ	NULL
aan	NULL
#	NULL
#	NULL
nin	NULL
#	NULL
s	NULL
#	NULL
>	NULL
%	NULL
o	NULL
@	NULL
B	NULL
o	NULL
l	NULL
&	NULL
E	NULL
s	NULL
£	NULL
&	NULL
.o	NULL
``	NULL
``	NULL
$	NULL
(	NULL
x	NULL
%	NULL
~	NULL
<	NULL
0	NULL
®	NULL
@	NULL
Y	NULL
0	NULL
%	NULL
ot	NULL
ot	NULL
ot	NULL
¢	NULL
``	NULL
0	NULL
&	NULL
&	NULL
0	NULL
``	NULL
g	NULL
``	NULL
0	NULL
``	NULL
o	NULL
PC	NULL
Q	NULL
a	NULL
aA	NULL
qt	NULL
at	NULL
qt	NULL
qt	NULL
qt	NULL
ru	NULL
“	NULL
“	NULL
.ﬂ	NULL
``	NULL
I	NULL
wa	NULL
to	NULL
«	NULL
o	NULL
to	NULL
tto	NULL
to	NULL
we	NULL
**	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
Ramos	NULL
cells	NULL
after	NULL
exposure	NULL
to	NULL
ionizing	NULL
radiation	NULL
or	NULL
H	NULL
;	NULL
,0	NULL
,	NULL
.	NULL

EMSA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Ramos	NULL
cells	NULL
were	NULL
irradiated	NULL
with	NULL
5	NULL
to	NULL
20	NULL
Gy	NULL
y-rays	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
pretreated	NULL
at	NULL
37°C	NULL
with	NULL
20	NULL
mmol/L	NULL
NAC	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
370	NULL
umol/L	NULL
genistein	NULL
for	NULL
1	NULL
hour	NULL
{	NULL
GEN	NULL
}	NULL
,	NULL
or	NULL
12	NULL
mol/L	NULL
herbimycin	NULL
(	NULL
HERB	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
before	NULL
ionizing	NULL
radiation	NULL
.	NULL

Radiation-induced	NULL
DNA-protein	NULL
complexes	NULL
reflecting	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

Competition	NULL
(	NULL
COMP	NULL
)	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
excess	NULL
unlabeled	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ramos	NULL
cells	NULL
were	NULL
either	NULL
irradiated	NULL
with	NULL
10	NULL
Gy	NULL
y-rays	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
20	NULL
mmol/L	NULL
NAC	NULL
or	NULL
treated	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
;	NULL
0	NULL
;	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
370	NULL
umol/L	NULL
genistein	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
12	NULL
umol/L	NULL
herbimycin	NULL
for	NULL
24	NULL
hour	NULL
,	NULL
30	NULL
umol/L	NULL
H7	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
or	NULL
20	NULL
mmol/L	NULL
NAC	NULL
for	NULL
1	NULL
hour	NULL
before	NULL
treatment	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

flux	NULL
and	NULL
inositol	NULL
1,4	NULL
,	NULL
5-trisphosphate	NULL
production	NULL
.	NULL

SCHIEVEN	NULL
ET	NULL
AL	NULL
with	NULL
our	NULL
recent	NULL
studies	NULL
.	NULL
``	NULL

''	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
1A	NULL
,	NULL
NAC	NULL
substantially	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
DNA-NF-	NULL
«	NULL
B	NULL
protein	NULL
complexes	NULL
in	NULL
irradiated	NULL
Ramos	NULL
cells	NULL
.	NULL

This	NULL
unique	NULL
observation	NULL
indicates	NULL
that	NULL
ROI	NULL
generation	NULL
is	NULL
a	NULL
mandatory	NULL
step	NULL
in	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
next	NULL
compared	NULL
the	NULL
ability	NULL
of	NULL
1,000	NULL
cGy	NULL
y-rays	NULL
and	NULL
9	NULL
mmol/L	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Ramos	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1B	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
ionizing	NULL
radiation	NULL
in	NULL
inducing	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
NAC	NULL
prevented	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
irradiated	NULL
or	NULL
H,0	NULL
,	NULL
;	NULL
-treated	NULL
Ramos	NULL
cells	NULL
.	NULL

Notably	NULL
,	NULL
both	NULL
genistein	NULL
and	NULL
herbimycin	NULL
were	NULL
able	NULL
to	NULL
abrogate	NULL
the	NULL
H,0	NULL
;	NULL
,	NULL
-in-duced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
whereas	NULL
H7	NULL
was	NULL
not	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ROI-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
triggered	NULL
primarily	NULL
by	NULL
PTK	NULL
activation	NULL
and	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
PKC	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
might	NULL
thus	NULL
induce	NULL
other	NULL
kinases	NULL
such	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
PKC	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
with	NULL
Daudi	NULL
cells	NULL
(	NULL
F.	NULL
Uckun	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
also	NULL
observed	NULL
at	NULL
the	NULL
lower	NULL
concentration	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
of	NULL
300	NULL
umol/L	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
vanadate	NULL
plus	NULL
H	NULL
,	NULL
O	NULL
;	NULL
was	NULL
not	NULL
significantly	NULL
more	NULL
effective	NULL
than	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
alone	NULL
in	NULL
inducing	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
H	NULL
,	NULL
O	NULL
;	NULL
alone	NULL
delivers	NULL
a	NULL
sufficiently	NULL
strong	NULL
signal	NULL
.	NULL

Hydrogen	NULL
peroxide	NULL
plus	NULL
vanadate	NULL
strongly	NULL
induce	NULL
[	NULL
Ca®*	NULL
}	NULL
i	NULL
We	NULL
next	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
ROI	NULL
generator	NULL
H	NULL
,	NULL
O	NULL
,	NULL
alone	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
phosphotyrosine	NULL
phosphatase	NULL
inhibitor	NULL
vanadate	NULL
to	NULL
stimulate	NULL
calcium	NULL
signaling	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
gave	NULL
a	NULL
small	NULL
signal	NULL
in	NULL
Ramos	NULL
cells	NULL
,	NULL
whereas	NULL
vanadate	NULL
alone	NULL
gave	NULL
no	NULL
signal	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
gave	NULL
a	NULL
very	NULL
strong	NULL
signal	NULL
.	NULL

The	NULL
signal	NULL
generated	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
Ramos	NULL
Cells	NULL
H2aO2	NULL
Hp	NULL
0	NULL
;	NULL
(	NULL
0.3mM	NULL
)	NULL
H2	NULL
Op	NULL
(	NULL
1mM	NULL
)	NULL
(	NULL
0.3mM	NULL
)	NULL
+VO4	NULL
(	NULL
1mM	NULL
)	NULL
+V04	NULL
r	NULL
s	NULL
1T	NULL
<	NULL
9	NULL
F	NULL
s	NULL
[	NULL
ﬁe	NULL
1	NULL
«	NULL
UH	NULL
Ul	NULL
.	NULL

Hluul	NULL
lid	NULL
had	NULL
aas	NULL
ll	NULL
uk	NULL
adu	NULL
ad	NULL
a	NULL
Fig	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
vanadate	NULL
and	NULL
varying	NULL
concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
100	NULL
umol/L	NULL
vanadate	NULL
before	NULL
EMSA	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
reflecting	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATE	NULL
INDUCED	NULL
SIGNALS	NULL
-H	NULL
...	NULL
...	NULL
V	NULL
--	NULL
H+V	NULL
4	NULL
|-	NULL
<	NULL
£	NULL
al	NULL
iS	NULL
d	NULL
~*~	NULL
,	NULL
To	NULL
2	NULL
}	NULL
J	NULL
=~	NULL
&	NULL
/	NULL
CG	NULL
Q	NULL
1	NULL
1	NULL
1	NULL
1	NULL
|	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
TIME	NULL
(	NULL
min	NULL
}	NULL
Fig	NULL
3	NULL
.	NULL

[	NULL
Ca**	NULL
)	NULL
i	NULL
signals	NULL
in	NULL
Ramos	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
1	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
H	NULL
)	NULL
and	NULL
100	NULL
amol/L	NULL
orthovanadate	NULL
(	NULL
V	NULL
)	NULL
.	NULL

vanadate	NULL
also	NULL
gave	NULL
a	NULL
strong	NULL
signal	NULL
in	NULL
CEM	NULL
cells	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
and	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EGTA	NULL
,	NULL
showing	NULL
that	NULL
Ca*+*	NULL
was	NULL
released	NULL
from	NULL
internal	NULL
stores	NULL
as	NULL
well	NULL
as	NULL
entered	NULL
cells	NULL
from	NULL
the	NULL
outside	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
the	NULL
calcium	NULL
signal	NULL
was	NULL
significantly	NULL
greater	NULL
than	NULL
that	NULL
observed	NULL
after	NULL
antibody	NULL
cross-linking	NULL
of	NULL
CD3	NULL
with	NULL
CD4	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
the	NULL
strongest	NULL
biologic	NULL
stimulations	NULL
for	NULL
[	NULL
Ca®*Ji	NULL
signals	NULL
in	NULL
CEM	NULL
cells	NULL
.	NULL
``	NULL

Treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
alone	NULL
gave	NULL
a	NULL
small	NULL
but	NULL
significant	NULL
[	NULL
Ca®*li	NULL
signal	NULL
,	NULL
whereas	NULL
vanadate	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
.	NULL

Sequential	NULL
treatment	NULL
with	NULL
the	NULL
compounds	NULL
in	NULL
either	NULL
order	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
the	NULL
use	NULL
of	NULL
both	NULL
together	NULL
in	NULL
generating	NULL
a	NULL
[	NULL
Ca**	NULL
]	NULL
i	NULL
signal	NULL
(	NULL
Fig	NULL
4D	NULL
)	NULL
.	NULL

Downmodulation	NULL
of	NULL
CD3	NULL
by	NULL
antibody	NULL
treatment	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
ROL-induced	NULL
signaling	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
although	NULL
signaling	NULL
via	NULL
CD2	NULL
was	NULL
inhibited	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL
``	NULL

The	NULL
[	NULL
Ca*+*	NULL
]	NULL
i	NULL
signal	NULL
in	NULL
1215	NULL
duced	NULL
by	NULL
ROI	NULL
treatment	NULL
is	NULL
therefore	NULL
independent	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
ROL-induced	NULL
[	NULL
Ca**	NULL
]	NULL
i	NULL
signal	NULL
in	NULL
lymphocytes	NULL
,	NULL
we	NULL
examined	NULL
Ins-1,4,5-P	NULL
;	NULL
levels	NULL
in	NULL
Ramos	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
resulted	NULL
in	NULL
rapid	NULL
,	NULL
substantial	NULL
,	NULL
but	NULL
transient	NULL
Ins-1,4,5-P	NULL
,	NULL
production	NULL
,	NULL
whereas	NULL
vanadate	NULL
alone	NULL
had	NULL
little	NULL
effect	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
accelerated	NULL
and	NULL
increased	NULL
Ins-1,4,5-P	NULL
,	NULL
production	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
Ins-1,4,5-P	NULL
,	NULL
were	NULL
thus	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
the	NULL
[	NULL
Ca*+	NULL
]	NULL
i	NULL
signals	NULL
observed	NULL
in	NULL
Ramos	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
other	NULL
B-cell	NULL
lines	NULL
including	NULL
Daudi	NULL
(	NULL
early	NULL
B	NULL
)	NULL
,	NULL
NALM-6	NULL
(	NULL
pre-B	NULL
)	NULL
,	NULL
REH	NULL
(	NULL
pre-pre-B	NULL
)	NULL
,	NULL
and	NULL
FL8.2	NULL
(	NULL
pro-B	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
effect	NULL
occurs	NULL
in	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
previous	NULL
reports	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
stimulated	NULL
polyphosphoinositide	NULL
breakdown	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
,	NULL
by	NULL
ROI	NULL
was	NULL
blocked	NULL
by	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
PKC	NULL
inhibitor	NULL
H7	NULL
.	NULL

Therefore	NULL
,	NULL
stimulation	NULL
of	NULL
Ins-1,4,5-P	NULL
,	NULL
production	NULL
by	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
is	NULL
dependent	NULL
on	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

Hydrogen	NULL
peroxide	NULL
and	NULL
vanadate	NULL
act	NULL
synergistically	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
physiologically	NULL
relevant	NULL
substrates	NULL
in	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
.	NULL

We	NULL
had	NULL
previously	NULL
reported	NULL
that	NULL
ionizing	NULL
radiation	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
which	NULL
was	NULL
greatly	NULL
augmented	NULL
by	NULL
vanadate	NULL
.	NULL
``	NULL

The	NULL
combination	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
synergistically	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
insulin-responsive	NULL
rat	NULL
adipocytes	NULL
.	NULL

>	NULL
``	NULL
``	NULL
``	NULL
While	NULL
the	NULL
present	NULL
study	NULL
was	NULL
under	NULL
review	NULL
,	NULL
a	NULL
similar	NULL
effect	NULL
was	NULL
described	NULL
for	NULL
T	NULL
cells	NULL
,	NULL
``	NULL
but	NULL
no	NULL
substrates	NULL
were	NULL
identified	NULL
.	NULL

The	NULL
current	NULL
finding	NULL
that	NULL
the	NULL
ROI	NULL
generator	NULL
H	NULL
,	NULL
O	NULL
,	NULL
induced	NULL
transient	NULL
Ins-1,4,5-P	NULL
;	NULL
,	NULL
and	NULL
[	NULL
Ca*+	NULL
]	NULL
i	NULL
signals	NULL
that	NULL
were	NULL
augmented	NULL
and	NULL
stabilized	NULL
by	NULL
vanadate	NULL
led	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
reagents	NULL
on	NULL
physio-	NULL
H+V	NULL
C	NULL
--	NULL
-H	NULL
--	NULL
--	NULL
--	NULL
-	NULL
H+V	NULL
,	NULL
EGTA	NULL
[	NULL
C02+	NULL
]	NULL
L	NULL
{	NULL
indo-1	NULL
ratio	NULL
)	NULL
TJ	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
[	NULL
Ca®	NULL
'	NULL
]	NULL
i	NULL
signals	NULL
in	NULL
CEM	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
H	NULL
)	NULL
and	NULL
100	NULL
amol/L	NULL
f	NULL
orthovanadate	NULL
(	NULL
V	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Signal	NULL
in	NULL
presence	NULL
of	NULL
10	NULL
mmol/L	NULL
EGTA	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Comparison	NULL
to	NULL
signal	NULL
generated	NULL
--	NULL
D	NULL
--	NULL
v	NULL
then	NULL
H	NULL
my	NULL
--	NULL
--	NULL
--	NULL
-	NULL
CD3	NULL
x	NULL
CO4	NULL
Fo	NULL
see	NULL
H	NULL
then	NULL
V	NULL
``	NULL
by	NULL
cross-linking	NULL
CD3	NULL
and	NULL
CD4	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Separate	NULL
treat-	NULL
0	NULL
4g	NULL
A	NULL
é	NULL
g	NULL
10	NULL
0	NULL
é	NULL
A	NULL
é	NULL
é	NULL
10	NULL
ment	NULL
with	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
and	NULL
vanadate	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Sequential	NULL
.	NULL

.	NULL

treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
.	NULL

Time	NULL
(	NULL
min	NULL
)	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1216	NULL
SCHIEVEN	NULL
ET	NULL
AL	NULL
Table	NULL
1	NULL
.	NULL

Induction	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
,	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
Vanadate	NULL
Ins-1,4,5-P	NULL
,	NULL
(	NULL
pmol/10®	NULL
RAMOS	NULL
cells	NULL
)	NULL
H	NULL
;	NULL
0	NULL
;	NULL
H202	NULL
H	NULL
;	NULL
02	NULL
Time	NULL
PBS	NULL
H	NULL
,	NULL
O	NULL
;	NULL
+	NULL
VO	NULL
,	NULL
+	NULL
VO	NULL
,	NULL
+	NULL
HERB	NULL
+	NULL
VO	NULL
,	NULL
+	NULL
H7	NULL
VO	NULL
,	NULL
0	NULL
3.8	NULL
+	NULL
0.3	NULL
3.8	NULL
+	NULL
0.3	NULL
3.8	NULL
+	NULL
0.3	NULL
3.8	NULL
£0.83	NULL
3.8	NULL
£	NULL
0.3	NULL
3.8	NULL
+	NULL
0.3	NULL
10	NULL
s	NULL
1.7	NULL
%	NULL
1.1	NULL
7.2	NULL
+	NULL
0.2	NULL
33.0	NULL
%	NULL
1.5	NULL
3.4	NULL
+	NULL
0.1	NULL
26.93	NULL
%	NULL
1.4	NULL
4.0	NULL
+	NULL
0.5	NULL
15	NULL
s	NULL
2.6	NULL
%	NULL
1.2	NULL
26.1	NULL
£	NULL
2.56	NULL
53.2	NULL
*	NULL
6.3	NULL
7A	NULL
%	NULL
1.1	NULL
51.7	NULL
#	NULL
2.9	NULL
6.2	NULL
+	NULL
0.5	NULL
30	NULL
s	NULL
52	NULL
%	NULL
1.93	NULL
49.7	NULL
+	NULL
12.7	NULL
118.8	NULL
+	NULL
8.5	NULL
8.4	NULL
+	NULL
5.2	NULL
102.9	NULL
+	NULL
4.0	NULL
10.3	NULL
+	NULL
0.9	NULL
45	NULL
s	NULL
3A	NULL
%	NULL
1.1	NULL
61.7	NULL
+	NULL
12.8	NULL
192.8	NULL
+	NULL
4.7	NULL
10.0	NULL
+	NULL
3.6	NULL
175.1	NULL
£	NULL
2.1	NULL
16.8	NULL
+	NULL
1.4	NULL
1	NULL
min	NULL
3.7	NULL
«	NULL
1.0	NULL
117.9	NULL
+	NULL
6.7	NULL
182.1	NULL
+	NULL
6.4	NULL
8.6	NULL
+	NULL
3.4	NULL
161.9	NULL
+	NULL
7.6	NULL
13.4	NULL
+	NULL
0.3	NULL
3	NULL
min	NULL
2.4	NULL
+	NULL
1.4	NULL
36.2	NULL
+	NULL
12.2	NULL
27.9	NULL
+	NULL
6.7	NULL
6.0	NULL
+	NULL
1.8	NULL
23.7	NULL
+	NULL
5.4	NULL
4.1	NULL
£0.3	NULL
5	NULL
min	NULL
2.4	NULL
+	NULL
0.9	NULL
14.1	NULL
+	NULL
0.9	NULL
11.9	NULL
+	NULL
1.5	NULL
4.3	NULL
+	NULL
0.5	NULL
7A	NULL
%	NULL
2.1	NULL
2.7	NULL
#	NULL
14	NULL
Cells	NULL
were	NULL
treated	NULL
with	NULL
3	NULL
mmol/L	NULL
H	NULL
;	NULL
0	NULL
;	NULL
,	NULL
100	NULL
«	NULL
mol/L	NULL
vanadate	NULL
(	NULL
VO	NULL
,	NULL
)	NULL
,	NULL
Herbimycin	NULL
A	NULL
(	NULL
HERB	NULL
)	NULL
,	NULL
and	NULL
H7	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
Ins-1,4,5-P	NULL
;	NULL
3.	NULL
logically	NULL
relevant	NULL
substrates	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
resulting	NULL
from	NULL
biologic	NULL
stimulations	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5A	NULL
,	NULL
treatment	NULL
of	NULL
CEM	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
many	NULL
proteins	NULL
with	NULL
molecular	NULL
weights	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
proteins	NULL
in	NULL
which	NULL
phosphorylation	NULL
was	NULL
induced	NULL
by	NULL
cross-linking	NULL
CD3	NULL
alone	NULL
or	NULL
cross-linking	NULL
CD3	NULL
and	NULL
CD4	NULL
.	NULL

However	NULL
,	NULL
the	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
approximately	NULL
10	NULL
times	NULL
greater	NULL
for	NULL
many	NULL
of	NULL
the	NULL
proteins	NULL
after	NULL
chemical	NULL
stimulation	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
Ramos	NULL
cells	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
,	NULL
chemical	NULL
stimulation	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
many	NULL
proteins	NULL
with	NULL
molecular	NULL
weights	NULL
comparable	NULL
to	NULL
those	NULL
observed	NULL
after	NULL
sIgM	NULL
cross-linking	NULL
,	NULL
but	NULL
at	NULL
much	NULL
higher	NULL
levels	NULL
.	NULL

A	NULL
CEM	NULL
B	NULL
Ramos	NULL
I	NULL
To	NULL
.-	NULL
s	NULL
S	NULL
2	NULL
Z	NULL
z	NULL
ese	NULL
R	NULL
y	NULL
&	NULL
=	NULL
g	NULL
&	NULL
<	NULL
N	NULL
9	NULL
Stim	NULL
:	NULL
ce	NULL
m	NULL
m	NULL
z	NULL
~	NULL
Stim	NULL
:	NULL
+	NULL
>	NULL
o	NULL
9	NULL
2	NULL
g	NULL
9	NULL
©	NULL
Z	NULL
5	NULL
_	NULL
5	NULL
S	NULL
C	NULL
kDa	NULL
f	NULL
L	NULL
2	NULL
TGI	NULL
I	NULL
4	NULL
219-	NULL
kDa	NULL
219-100-	NULL
a	NULL
&	NULL
=	NULL
``	NULL
7	NULL
@	NULL
67_	NULL
.	NULL

f	NULL
y	NULL
loo—	NULL
=	NULL
%	NULL
er-42	NULL
7-	NULL
i	NULL
&	NULL
-	NULL
3	NULL
42.7-	NULL
``	NULL
€	NULL
274	NULL
,	NULL
274-	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Antiphosphotyrosine	NULL
immunoblot	NULL
comparison	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
chemical	NULL
and	NULL
biologic	NULL
stimulations	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CEM	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
by	NULL
cross-linking	NULL
CD3	NULL
or	NULL
CD3	NULL
and	NULL
CD4	NULL
for	NULL
1	NULL
minute	NULL
using	NULL
biotinylated	NULL
antibodies	NULL
,	NULL
or	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
100	NULL
umol/L	NULL
vanadate	NULL
(	NULL
HV	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

An	NULL
HV	NULL
sample	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
(	NULL
0.1	NULL
X	NULL
)	NULL
was	NULL
also	NULL
prepared	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ramos	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
6	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
;	NULL
alone	NULL
(	NULL
H	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
100	NULL
umol/L	NULL
vanadate	NULL
(	NULL
HV	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
or	NULL
for	NULL
anti-IgM	NULL
stimulation	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

For	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
also	NULL
induced	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
not	NULL
readily	NULL
observed	NULL
after	NULL
biologic	NULL
stimulation	NULL
.	NULL

PLCy1	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
for	NULL
2	NULL
minutes	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
several	NULL
PLCy1-asso-ciated	NULL
proteins	NULL
,	NULL
including	NULL
pp35/36	NULL
,	NULL
which	NULL
associate	NULL
via	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
PLCy1	NULL
,	NULL
**	NULL
were	NULL
also	NULL
tyrosine	NULL
phosphory-lated	NULL
.	NULL

The	NULL
anti-PLCy1	NULL
Western	NULL
blot	NULL
showed	NULL
that	NULL
,	NULL
although	NULL
equal	NULL
amounts	NULL
of	NULL
PLCy	NULL
1	NULL
protein	NULL
were	NULL
recovered	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
vanadate	NULL
alone	NULL
as	NULL
from	NULL
untreated	NULL
cells	NULL
,	NULL
less	NULL
was	NULL
recovered	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
vanadate	NULL
together	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
fraction	NULL
of	NULL
PLCy	NULL
1	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
is	NULL
greater	NULL
than	NULL
what	NULL
is	NULL
initially	NULL
apparent	NULL
from	NULL
Fig	NULL
6A	NULL
.	NULL

Vanadate	NULL
was	NULL
required	NULL
to	NULL
stabilize	NULL
and	NULL
augment	NULL
the	NULL
ROI	NULL
signal	NULL
before	NULL
this	NULL
phosphorylation	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

The	NULL
tyrosine	NULL
kinase-dependent	NULL
induction	NULL
of	NULL
Ins-1,4,5-P	NULL
;	NULL
,	NULL
by	NULL
ROI	NULL
and	NULL
the	NULL
ROI-induced	NULL
[	NULL
Ca**Ji	NULL
signals	NULL
may	NULL
thus	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PLCy	NULL
1	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
6B	NULL
,	NULL
GAP	NULL
and	NULL
associated	NULL
proteins	NULL
,	NULL
including	NULL
species	NULL
appearing	NULL
to	NULL
be	NULL
the	NULL
GAP	NULL
-associated	NULL
proteins	NULL
p190®	NULL
and	NULL
p62	NULL
,	NULL
``	NULL
°	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
.	NULL

The	NULL
{	NULL
subunit	NULL
of	NULL
the	NULL
TCR	NULL
was	NULL
also	NULL
phosphorylated	NULL
(	NULL
Fig	NULL
6C	NULL
)	NULL
.	NULL

Although	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
ROI	NULL
induction	NULL
of	NULL
[	NULL
Ca**	NULL
]	NULL
i	NULL
signals	NULL
does	NULL
not	NULL
require	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
a	NULL
TCR	NULL
component	NULL
is	NULL
acted	NULL
upon	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
many	NULL
other	NULL
proteins	NULL
,	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
state	NULL
of	NULL
p34	NULL
remained	NULL
unchanged	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
not	NULL
all	NULL
proteins	NULL
that	NULL
can	NULL
be	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
are	NULL
affected	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
plus	NULL
vanadate	NULL
activates	NULL
p56	NULL
``	NULL
*	NULL
and	NULL
p59	NULL
``	NULL
tyrosine	NULL
kinases	NULL
.	NULL

-	NULL
The	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
in	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
ascribed	NULL
to	NULL
inhibition	NULL
of	NULL
phosphatases	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
strong	NULL
phosphorylation	NULL
of	NULL
physiologically	NULL
relevant	NULL
substrates	NULL
led	NULL
us	NULL
to	NULL
examine	NULL
effects	NULL
on	NULL
kinase	NULL
activity	NULL
as	NULL
well	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
p56	NULL
``	NULL
from	NULL
Ramos	NULL
cells	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
and	NULL
both	NULL
p56	NULL
``	NULL
*®	NULL
and	NULL
p59	NULL
``	NULL
from	NULL
CEM	NULL
cells	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
was	NULL
markedly	NULL
stimulated	NULL
by	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
showing	NULL
increased	NULL
activity	NULL
toward	NULL
the	NULL
exogenous	NULL
substrate	NULL
enolase	NULL
after	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
,	NULL
p56	NULL
``	NULL
*	NULL
had	NULL
a	NULL
characteristic	NULL
shift	NULL
to	NULL
a	NULL
lower	NULL
mobil-ity	NULL
.	NULL

This	NULL
shift	NULL
in	NULL
p56	NULL
``	NULL
mobility	NULL
has	NULL
been	NULL
specifically	NULL
observed	NULL
early	NULL
in	NULL
lymphocyte	NULL
activation	NULL
and	NULL
after	NULL
treatment	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATE	NULL
INDUCED	NULL
SIGNALS	NULL
1217	NULL
PLCy|	NULL
IP	NULL
GAP	NULL
and	NULL
p34°4°2	NULL
Ip	NULL
Zeta	NULL
IP	NULL
Anti-p-tyr	NULL
Blot	NULL
Anti-p-tyr	NULL
Blot	NULL
Anti-PLC	NULL
Anti-p-tyr	NULL
p.	NULL
Anti-	NULL
Anti-Blot	NULL
Blot	NULL
IP	NULL
:	NULL
gap	NULL
_	NULL
p3acdc2	NULL
Stim	NULL
:	NULL
0	NULL
H	NULL
V	NULL
HV	NULL
0	NULL
HV	NULL
HV	NULL
Stim	NULL
:	NULL
0	NULL
HV	NULL
O	NULL
HV	NULL
Stim	NULL
:	NULL
0	NULL
_	NULL
HV	NULL
kDa	NULL
kDa	NULL
kDa	NULL
219-	NULL
219-	NULL
a	NULL
100-PLCy	NULL
{	NULL
+	NULL
--	NULL
«	NULL
ges	NULL
67-	NULL
_	NULL
»	NULL
100-	NULL
100-	NULL
p4	NULL
a2	NULL
7	NULL
tn	NULL
Ue	NULL
s7-	NULL
a	NULL
,	NULL
Fig	NULL
6	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
specific	NULL
pro-	NULL
;	NULL
4	NULL
.	NULL

274-teins	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
;	NULL
“	NULL
a	NULL
»	NULL
a27-	NULL
®	NULL
(	NULL
H	NULL
)	NULL
,	NULL
100	NULL
amol/L	NULL
orthovanadate	NULL
(	NULL
V	NULL
)	NULL
,	NULL
both	NULL
(	NULL
HV	NULL
)	NULL
,	NULL
or	NULL
no	NULL
35/36	NULL
zeta	NULL
»	NULL
.	NULL

treatment	NULL
(	NULL
0	NULL
)	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
immunoprecipitation	NULL
pP	NULL
cuss	NULL
followed	NULL
by	NULL
immunoblotting	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Phosphorylation	NULL
ara	NULL
p34	NULL
~	NULL
@	NULL
@	NULL
18-274	NULL
``	NULL
of	NULL
PLCy1	NULL
and	NULL
associated	NULL
proteins	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Phosphorylation	NULL
of	NULL
GAP	NULL
and	NULL
p34	NULL
``	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Phosphorylation	NULL
of	NULL
{	NULL
chain	NULL
.	NULL

with	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL
``	NULL

The	NULL
amount	NULL
of	NULL
p56	NULL
``	NULL
*	NULL
that	NULL
could	NULL
be	NULL
detected	NULL
by	NULL
immunoblot	NULL
analysis	NULL
was	NULL
significantly	NULL
reduced	NULL
by	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
(	NULL
Fig	NULL
8C	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
specific	NULL
activity	NULL
of	NULL
p56	NULL
``	NULL
*	NULL
is	NULL
thus	NULL
greater	NULL
than	NULL
what	NULL
is	NULL
apparent	NULL
in	NULL
Fig	NULL
8A	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
with	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
or	NULL
vanadate	NULL
alone	NULL
did	NULL
not	NULL
stimulate	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
kinases	NULL
.	NULL

This	NULL
finding	NULL
that	NULL
ROI	NULL
alone	NULL
did	NULL
not	NULL
activate	NULL
p56	NULL
``	NULL
*	NULL
or	NULL
p59	NULL
``	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
study	NULL
showing	NULL
that	NULL
ionizing	NULL
radiation	NULL
did	NULL
not	NULL
substantially	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
kinases	NULL
.	NULL
``	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
7	NULL
,	NULL
p56	NULL
``	NULL
*	NULL
activity	NULL
did	NULL
not	NULL
increase	NULL
after	NULL
irradiation	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
vanadate	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
p56	NULL
``	NULL
*	NULL
activation	NULL
after	NULL
irradiation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
vanadate	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
radiation	NULL
generating	NULL
lower	NULL
amounts	NULL
of	NULL
ROI	NULL
relative	NULL
to	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
9	NULL
mmol/	NULL
p56	NULL
!	NULL

immune	NULL
Complex	NULL
Kinase	NULL
Assay	NULL
RAMOS	NULL
Cells	NULL
[	NULL
5	NULL
o	NULL
.o	NULL
.o	NULL
x4	NULL
&	NULL
``	NULL
nt	NULL
ay	NULL
O	NULL
o	NULL
P	NULL
@	NULL
$	NULL
or	NULL
N9	NULL
o	NULL
ICK	NULL
-	NULL
»	NULL
~~	NULL
‘	NULL
-u~	NULL
‘	NULL
tnose	NULL
>	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
Immune	NULL
complex	NULL
kinase	NULL
assay	NULL
of	NULL
p56	NULL
``	NULL
after	NULL
treatment	NULL
of	NULL
Ramos	NULL
cells	NULL
with	NULL
y-radiation	NULL
,	NULL
9	NULL
mmol/L	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
and	NULL
100	NULL
amol/L	NULL
vanadate	NULL
.	NULL

L	NULL
H,0	NULL
;	NULL
,	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
p62	NULL
``	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
vanadate	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
acted	NULL
directly	NULL
on	NULL
the	NULL
responsive	NULL
kinases	NULL
,	NULL
immunoprecipitates	NULL
were	NULL
treated	NULL
directly	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
100	NULL
mol/L	NULL
vanadate	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
the	NULL
kinase	NULL
reaction	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
.	NULL

Chemical	NULL
treatment	NULL
reduced	NULL
the	NULL
activity	NULL
of	NULL
p56	NULL
``	NULL
*	NULL
and	NULL
p59	NULL
``	NULL
,	NULL
in	NULL
terms	NULL
of	NULL
autophosphorylation	NULL
as	NULL
well	NULL
as	NULL
phosphorylation	NULL
of	NULL
enolase	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
vanadate	NULL
in	NULL
treated	NULL
cells	NULL
are	NULL
unknown	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
observed	NULL
in	NULL
treated	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
a	NULL
direct	NULL
reaction	NULL
of	NULL
the	NULL
enzymes	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
.	NULL

DISCUSSION	NULL
The	NULL
biochemical	NULL
mechanisms	NULL
responsible	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
have	NULL
been	NULL
the	NULL
focus	NULL
of	NULL
extensive	NULL
research	NULL
.	NULL

Brach	NULL
et	NULL
al°	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
ionizing	NULL
radiation	NULL
induces	NULL
expression	NULL
and	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
KG-1	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

Schreck	NULL
et	NULL
al	NULL
}	NULL
recently	NULL
provided	NULL
evidence	NULL
that	NULL
diverse	NULL
agents	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
a	NULL
common	NULL
mechanism	NULL
involving	NULL
the	NULL
synthesis	NULL
of	NULL
ROI	NULL
.	NULL

Herbimycin	NULL
A	NULL
has	NULL
been	NULL
found	NULL
to	NULL
block	NULL
interleukin-1-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
we	NULL
found	NULL
that	NULL
radiation-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
triggered	NULL
by	NULL
stimulation	NULL
of	NULL
tyrosine-specific	NULL
kinases	NULL
and	NULL
can	NULL
be	NULL
abrogated	NULL
by	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
herbimycin	NULL
and	NULL
genistein	NULL
.	NULL
'	NULL

''	NULL
Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
prompted	NULL
the	NULL
hypotheses	NULL
that	NULL
the	NULL
biochemical	NULL
signals	NULL
induced	NULL
by	NULL
ionizing	NULL
radiation	NULL
are	NULL
dependent	NULL
on	NULL
the	NULL
generation	NULL
of	NULL
ROI	NULL
and	NULL
that	NULL
many	NULL
of	NULL
the	NULL
pleiotropic	NULL
effects	NULL
of	NULL
ROI	NULL
on	NULL
human	NULL
lymphoid	NULL
cells	NULL
are	NULL
triggered	NULL
by	NULL
stimulation	NULL
of	NULL
tyrosine-specific	NULL
protein	NULL
kinases	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
hypothesis	NULL
by	NULL
determining	NULL
whether	NULL
NAC	NULL
and	NULL
herbimycin	NULL
could	NULL
inhibit	NULL
strong	NULL
signals	NULL
induced	NULL
by	NULL
substantial	NULL
doses	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
radiation	NULL
previously	NULL
reported	NULL
to	NULL
be	NULL
optimal	NULL
.	NULL

*	NULL
``	NULL
>	NULL
``	NULL
>	NULL
``	NULL
Furthermore	NULL
,	NULL
we	NULL
examined	NULL
cell	NULL
responses	NULL
within	NULL
a	NULL
short	NULL
time	NULL
of	NULL
treatment	NULL
.	NULL

Although	NULL
20	NULL
Gy	NULL
of	NULL
gamma	NULL
irradiation	NULL
will	NULL
kill	NULL
over	NULL
90	NULL
%	NULL
of	NULL
Ramos	NULL
cells	NULL
,	NULL
this	NULL
does	NULL
not	NULL
occur	NULL
for	NULL
3	NULL
to	NULL
7	NULL
days	NULL
and	NULL
no	NULL
change	NULL
in	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
occurs	NULL
in	NULL
the	NULL
first	NULL
24	NULL
to	NULL
48	NULL
hours	NULL
(	NULL
F.	NULL
Uckun	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

The	NULL
short	NULL
exposures	NULL
of	NULL
Ramos	NULL
cells	NULL
to	NULL
H	NULL
,	NULL
O	NULL
;	NULL
reported	NULL
here	NULL
result	NULL
in	NULL
no	NULL
change	NULL
in	NULL
viability	NULL
even	NULL
48	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1218	NULL
A	NULL
Kinase	NULL
Assays	NULL
Following	NULL
Cell	NULL
Treatment	NULL
Ick	NULL
fyn	NULL
SCHIEVEN	NULL
ET	NULL
AL	NULL
yes	NULL
Treatment	NULL
:	NULL
O	NULL
H	NULL
V	NULL
HV	NULL
0	NULL
H	NULL
V	NULL
HV	NULL
+-	NULL
®	NULL
~	NULL
~	NULL
~	NULL
*~	NULL
Enoicse-	NULL
Coat	NULL
.	NULL

ape-asdiP	NULL
0	NULL
H	NULL
V	NULL
HV	NULL
#	NULL
¥®T	NULL
B	NULL
Assay	NULL
Following	NULL
C	NULL
-	NULL
Anti-p56	NULL
!	NULL

ck	NULL
Treatment	NULL
of	NULL
Kinase	NULL
Blot	NULL
Ick	NULL
fyn	NULL
i	NULL
'	NULL
'	NULL
'	NULL
Fig	NULL
8	NULL
.	NULL

Immune	NULL
complex	NULL
kinase	NULL
assays	NULL
after	NULL
Treatment	NULL
:	NULL
-	NULL
O	NULL
HV	NULL
O	NULL
HV	NULL
treatment	NULL
of	NULL
CEM	NULL
cells	NULL
with	NULL
9	NULL
mmol/L	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
H	NULL
)	NULL
,	NULL
hours	NULL
after	NULL
treatment	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
NAC	NULL
and	NULL
herbimycin	NULL
to	NULL
inhibit	NULL
the	NULL
signals	NULL
from	NULL
such	NULL
substantial	NULL
dosages	NULL
shows	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
ROI	NULL
and	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
.	NULL

Our	NULL
findings	NULL
that	NULL
lower	NULL
doses	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
300	NULL
mol/L	NULL
)	NULL
and	NULL
radiation	NULL
(	NULL
5	NULL
Gy	NULL
)	NULL
also	NULL
gave	NULL
similar	NULL
results	NULL
shows	NULL
that	NULL
the	NULL
effects	NULL
are	NULL
not	NULL
unique	NULL
to	NULL
high	NULL
doses	NULL
.	NULL

NAC	NULL
alone	NULL
does	NULL
not	NULL
depress	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
F.	NULL
Uckun	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
acting	NULL
only	NULL
as	NULL
a	NULL
free	NULL
radical	NULL
scavenger	NULL
and	NULL
not	NULL
as	NULL
a	NULL
kinase	NULL
inhibitor	NULL
.	NULL

The	NULL
inhibitor	NULL
studies	NULL
thus	NULL
indicate	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
radiation	NULL
was	NULL
dependent	NULL
on	NULL
ROI	NULL
generation	NULL
and	NULL
,	NULL
furthermore	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
ROI	NULL
was	NULL
dependent	NULL
on	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

The	NULL
augmentation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
effect	NULL
previously	NULL
observed	NULL
when	NULL
vanadate-treated	NULL
cells	NULL
were	NULL
irradiated	NULL
,	NULL
``	NULL
indicating	NULL
a	NULL
common	NULL
mechanism	NULL
.	NULL

The	NULL
ROI-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
lymphoid	NULL
cells	NULL
led	NULL
to	NULL
downstream	NULL
events	NULL
including	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
Ins-1,4,5-P	NULL
,	NULL
generation	NULL
,	NULL
and	NULL
[	NULL
Ca®*	NULL
]	NULL
i	NULL
signals	NULL
.	NULL

Additional	NULL
signal	NULL
transduction	NULL
pathways	NULL
such	NULL
as	NULL
those	NULL
involving	NULL
ras	NULL
and	NULL
GAP	NULL
may	NULL
also	NULL
be	NULL
affected	NULL
.	NULL

Thus	NULL
,	NULL
ROI	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
may	NULL
account	NULL
for	NULL
many	NULL
of	NULL
the	NULL
pleiotropic	NULL
effects	NULL
of	NULL
ROI	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
whether	NULL
generated	NULL
chemically	NULL
or	NULL
by	NULL
ionizing	NULL
radiation	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
recent	NULL
finding	NULL
that	NULL
the	NULL
mammalian	NULL
UV	NULL
response	NULL
in	NULL
HeLa	NULL
cells	NULL
leading	NULL
to	NULL
c-/un	NULL
induction	NULL
is	NULL
triggered	NULL
by	NULL
src	NULL
kinases	NULL
and	NULL
inhibited	NULL
by	NULL
elevation	NULL
of	NULL
intracellular	NULL
glutathione	NULL
levels	NULL
.	NULL
``	NULL

''	NULL
The	NULL
identification	NULL
of	NULL
the	NULL
particular	NULL
ROI	NULL
species	NULL
involved	NULL
in	NULL
the	NULL
kinase	NULL
activation	NULL
,	NULL
as	NULL
has	NULL
been	NULL
performed	NULL
by	NULL
spin	NULL
trapping	NULL
precursors	NULL
of	NULL
thymine	NULL
damage	NULL
in	NULL
X-irradiated	NULL
DNA	NULL
,	NULL
*	NULL
could	NULL
provide	NULL
further	NULL
insights	NULL
into	NULL
the	NULL
mechanisms	NULL
involved	NULL
.	NULL

Treatment	NULL
:	NULL
O	NULL
HV	NULL
100	NULL
umol/L	NULL
vanadate	NULL
(	NULL
V	NULL
)	NULL
,	NULL
both	NULL
(	NULL
HV	NULL
)	NULL
,	NULL
or	NULL
no	NULL
treat-of	NULL
ment	NULL
(	NULL
0	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
treated	NULL
for	NULL
30	NULL
minutes	NULL
beg	NULL
fore	NULL
lysis	NULL
and	NULL
kinase	NULL
assay	NULL
.	NULL

Autoradiography	NULL
for	NULL
e	NULL
%	NULL
p62Y**	NULL
assay	NULL
is	NULL
a	NULL
fivefold	NULL
longer	NULL
exposure	NULL
than	NULL
for	NULL
p56	NULL
``	NULL
and	NULL
p59	NULL
%	NULL
Y	NULL
``	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoprecipitates	NULL
of	NULL
p56'*	NULL
and	NULL
p59Y	NULL
``	NULL
were	NULL
treated	NULL
before	NULL
kinase	NULL
assay	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunoblot	NULL
of	NULL
p56	NULL
``	NULL
*	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL

The	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
cells	NULL
is	NULL
the	NULL
result	NULL
of	NULL
a	NULL
dynamic	NULL
equilibrium	NULL
between	NULL
the	NULL
opposing	NULL
activities	NULL
of	NULL
tyrosine	NULL
kinases	NULL
and	NULL
phosphotyrosine	NULL
phosphatases	NULL
.	NULL

*	NULL
'	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
vanadate	NULL
are	NULL
potent	NULL
phosphotyrosine	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
which	NULL
,	NULL
when	NULL
used	NULL
together	NULL
,	NULL
strongly	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
insulin-responsive	NULL
cells	NULL
such	NULL
as	NULL
Fao	NULL
cells	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
insulin	NULL
receptor	NULL
's	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
potent	NULL
phosphotyrosine	NULL
phosphatase	NULL
inhibitor	NULL
phenylarsine	NULL
oxide	NULL
(	NULL
PAO	NULL
)	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
inhibition	NULL
of	NULL
phosphatases	NULL
without	NULL
kinase	NULL
activation	NULL
,	NULL
``	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
on	NULL
lymphocytes	NULL
has	NULL
similarly	NULL
been	NULL
believed	NULL
to	NULL
be	NULL
only	NULL
due	NULL
to	NULL
phosphatase	NULL
inhibition	NULL
.	NULL
``	NULL

However	NULL
,	NULL
we	NULL
have	NULL
now	NULL
found	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
two	NULL
potent	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
,	NULL
stimulates	NULL
tyrosine	NULL
kinases	NULL
as	NULL
well	NULL
.	NULL

This	NULL
combination	NULL
of	NULL
kinase	NULL
activation	NULL
and	NULL
phosphatase	NULL
inhibition	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
hyperinduction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
triggering	NULL
of	NULL
an	NULL
ROI-sensitive	NULL
tyrosine	NULL
kinase	NULL
constitutes	NULL
the	NULL
initial	NULL
signal	NULL
,	NULL
followed	NULL
by	NULL
stabilization	NULL
of	NULL
the	NULL
resultant	NULL
tyrosine	NULL
phosphorylation	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
phosphatase	NULL
activity	NULL
.	NULL

The	NULL
signal	NULL
is	NULL
then	NULL
further	NULL
amplified	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
src	NULL
family	NULL
kinases	NULL
such	NULL
as	NULL
p56	NULL
``	NULL
*	NULL
and	NULL
p59°	NULL
%	NULL
``	NULL
.	NULL

The	NULL
continued	NULL
inhibition	NULL
of	NULL
phosphatase	NULL
activity	NULL
would	NULL
then	NULL
maintain	NULL
the	NULL
signal	NULL
at	NULL
high	NULL
levels	NULL
.	NULL

Notably	NULL
,	NULL
two	NULL
kinases	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
T-cell	NULL
sig-naling	NULL
,	NULL
p56	NULL
``	NULL
and	NULL
were	NULL
activated	NULL
,	NULL
whereas	NULL
p62	NULL
``	NULL
,	NULL
which	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
T-cell	NULL
signal-ing	NULL
,	NULL
was	NULL
not	NULL
affected	NULL
.	NULL

Furthermore	NULL
,	NULL
direct	NULL
reaction	NULL
of	NULL
H,0	NULL
,	NULL
plus	NULL
vanadate	NULL
did	NULL
not	NULL
activate	NULL
the	NULL
kinases	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
mediate	NULL
the	NULL
effects	NULL
of	NULL
chemical	NULL
treat	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATE	NULL
INDUCED	NULL
SIGNALS	NULL
ment	NULL
on	NULL
these	NULL
kinases	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
kinases	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
plus	NULL
vanadate	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
a	NULL
function	NULL
of	NULL
phosphatase	NULL
inhibition	NULL
alone	NULL
because	NULL
PAO	NULL
has	NULL
not	NULL
been	NULL
found	NULL
to	NULL
activate	NULL
kinases	NULL
.	NULL
``	NULL

CD45	NULL
phosphotyrosine	NULL
phosphatase	NULL
is	NULL
required	NULL
for	NULL
TCR-	NULL
and	NULL
CD2-mediated	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
biologic	NULL
receptor-mediated	NULL
stimulations	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
combination	NULL
of	NULL
two	NULL
potent	NULL
phosphatase	NULL
inhibitors	NULL
to	NULL
activate	NULL
tyrosine	NULL
kinases	NULL
shows	NULL
that	NULL
the	NULL
requirement	NULL
for	NULL
phosphatase	NULL
activity	NULL
can	NULL
be	NULL
circumvented	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
an	NULL
ROI	NULL
generator	NULL
plus	NULL
vanadate	NULL
led	NULL
to	NULL
high	NULL
levels	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
physiologically	NULL
relevant	NULL
proteins	NULL
.	NULL

This	NULL
phosphorylation	NULL
showed	NULL
evidence	NULL
of	NULL
specificity	NULL
in	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p34	NULL
was	NULL
not	NULL
affected	NULL
.	NULL

Because	NULL
phosphorylation	NULL
of	NULL
p34	NULL
``	NULL
is	NULL
regulated	NULL
in	NULL
response	NULL
to	NULL
incompletely	NULL
replicated	NULL
DNA	NULL
,	NULL
*	NULL
the	NULL
chemical	NULL
treatment	NULL
may	NULL
not	NULL
have	NULL
affected	NULL
that	NULL
particular	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
plus	NULL
vanadate	NULL
offer	NULL
a	NULL
method	NULL
we	NULL
are	NULL
currently	NULL
investigating	NULL
to	NULL
produce	NULL
substantial	NULL
quantities	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
substrates	NULL
for	NULL
purification	NULL
and	NULL
identification	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
ROI	NULL
on	NULL
lymphoid	NULL
cell	NULL
signal	NULL
transduction	NULL
may	NULL
have	NULL
important	NULL
consequences	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
disease	NULL
states	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
is	NULL
well	NULL
suited	NULL
as	NULL
a	NULL
messenger	NULL
because	NULL
it	NULL
can	NULL
freely	NULL
diffuse	NULL
across	NULL
cell	NULL
membranes	NULL
and	NULL
in	NULL
healthy	NULL
individuals	NULL
the	NULL
concentration	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
is	NULL
normally	NULL
quite	NULL
low	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
the	NULL
elevation	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
upon	NULL
viral	NULL
infection	NULL
or	NULL
inflammation	NULL
could	NULL
act	NULL
as	NULL
a	NULL
significant	NULL
signal	NULL
.	NULL

For	NULL
cells	NULL
already	NULL
activated	NULL
,	NULL
this	NULL
signal	NULL
might	NULL
be	NULL
expected	NULL
to	NULL
amplify	NULL
their	NULL
response	NULL
by	NULL
boosting	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
and	NULL
calcium	NULL
signaling	NULL
.	NULL

However	NULL
,	NULL
for	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
ROI	NULL
could	NULL
induce	NULL
a	NULL
calcium	NULL
signal	NULL
under	NULL
nonmitogenic	NULL
conditions	NULL
that	NULL
is	NULL
potentially	NULL
sufficient	NULL
to	NULL
induce	NULL
a	NULL
state	NULL
of	NULL
nonrespon-siveness	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
calcium	NULL
signals	NULL
induced	NULL
by	NULL
modulation	NULL
of	NULL
CD3	NULL
or	NULL
by	NULL
pulsing	NULL
with	NULL
calcium	NULL
iono-phores	NULL
.	NULL

*	NULL
``	NULL
*	NULL
``	NULL
``	NULL
It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
many	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemias	NULL
arise	NULL
from	NULL
a	NULL
combination	NULL
of	NULL
initial	NULL
mutations	NULL
followed	NULL
by	NULL
a	NULL
later	NULL
infection	NULL
.	NULL
``	NULL

The	NULL
ROI	NULL
generated	NULL
during	NULL
the	NULL
course	NULL
of	NULL
infection	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
this	NULL
process	NULL
,	NULL
because	NULL
ROI	NULL
are	NULL
tumor	NULL
promoters	NULL
.	NULL
``	NULL

Signals	NULL
induced	NULL
by	NULL
ROI	NULL
in	NULL
lymphoid	NULL
cells	NULL
with	NULL
accumulated	NULL
mutations	NULL
could	NULL
conceivably	NULL
tip	NULL
the	NULL
biochemical	NULL
balance	NULL
between	NULL
oncogenic	NULL
and	NULL
tumor	NULL
suppressor	NULL
proteins	NULL
in	NULL
favor	NULL
of	NULL
leukemogenesis	NULL
.	NULL

The	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
ROI	NULL
and	NULL
inhibited	NULL
by	NULL
NAC	NULL
``	NULL
via	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL
``	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
ROT-induced	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
this	NULL
process	NULL
.	NULL

ROT-induced	NULL
signals	NULL
in	NULL
lymphoid	NULL
cells	NULL
thus	NULL
offer	NULL
several	NULL
avenues	NULL
for	NULL
future	NULL
investigation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Halliwell	NULL
B	NULL
,	NULL
Gutteridge	NULL
JM	NULL
:	NULL
Free	NULL
Radicals	NULL
in	NULL
Biology	NULL
and	NULL
Med-icine	NULL
.	NULL

Oxford	NULL
,	NULL
UK	NULL
,	NULL
Clarendon	NULL
,	NULL
1989	NULL
2	NULL
.	NULL

Bauerle	NULL
PA	NULL
;	NULL
The	NULL
inducible	NULL
transcrition	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
Regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1072:63	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Schreck	NULL
R	NULL
,	NULL
Reiber	NULL
P	NULL
,	NULL
Bauerle	NULL
PA	NULL
:	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
10:2247	NULL
,	NULL
1991	NULL
1219	NULL
4	NULL
.	NULL

Wardman	NULL
P	NULL
:	NULL
Principles	NULL
of	NULL
radiation	NULL
chemistry	NULL
,	NULL
in	NULL
Steel	NULL
GG	NULL
,	NULL
Adams	NULL
GE	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
The	NULL
Biological	NULL
Basis	NULL
of	NULL
Radiotherapy	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Elsevier	NULL
,	NULL
1983	NULL
,	NULL
p	NULL
51	NULL
5	NULL
.	NULL

Brach	NULL
MA	NULL
,	NULL
Hass	NULL
R	NULL
,	NULL
Sherman	NULL
ML	NULL
,	NULL
Gunji	NULL
H	NULL
,	NULL
Weichselbaum	NULL
R	NULL
,	NULL
Kufe	NULL
D	NULL
:	NULL
lonizing	NULL
radiation	NULL
induces	NULL
expression	NULL
and	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
88:691	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Sherman	NULL
ML	NULL
,	NULL
Datta	NULL
R	NULL
,	NULL
Hallahan	NULL
DE	NULL
,	NULL
Weichselbaum	NULL
RR	NULL
,	NULL
Kufe	NULL
DW	NULL
:	NULL
Ionizing	NULL
radiation	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
pro-tooncogene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
§7:5663	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Hallahan	NULL
DE	NULL
,	NULL
Sukhatme	NULL
VP	NULL
,	NULL
Sherman	NULL
JL	NULL
,	NULL
Virudachalam	NULL
S	NULL
,	NULL
Kufe	NULL
D	NULL
,	NULL
Weichselbaum	NULL
RR	NULL
:	NULL
Protein	NULL
kinase	NULL
C	NULL
mediates	NULL
x-ray	NULL
induc-ibility	NULL
of	NULL
nuclear	NULL
signal	NULL
transducers	NULL
EGR	NULL
1	NULL
and	NULL
JUN	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:2156	NULL
,	NULL
1991	NULL
8	NULL
.	NULL

Gold	NULL
MR	NULL
,	NULL
Law	NULL
DA	NULL
,	NULL
DeFranco	NULL
AL	NULL
:	NULL
Stimulation	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
the	NULL
B-lymphocyte	NULL
antigen	NULL
receptor	NULL
.	NULL

Nature	NULL
345:8	NULL
10	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

June	NULL
CH	NULL
,	NULL
Fletcher	NULL
MC	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Samelson	NULL
LE	NULL
:	NULL
Increases	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
are	NULL
detectable	NULL
before	NULL
phospholipase	NULL
C	NULL
activation	NULL
after	NULL
T	NULL
cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

J	NULL
Immunol	NULL
144:1591	NULL
,	NULL
1990	NULL
10	NULL
.	NULL

Ledbetter	NULL
JA	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Kuebelbeck	NULL
VM	NULL
,	NULL
Uckun	NULL
FM	NULL
:	NULL
Accessory	NULL
receptors	NULL
regulate	NULL
coupling	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
complex	NULL
to	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
and	NULL
mobilization	NULL
of	NULL
cytoplasmic	NULL
calcium	NULL
in	NULL
T-lineage	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
771271	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

June	NULL
CH	NULL
,	NULL
Fletcher	NULL
MC	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Siegel	NULL
JN	NULL
,	NULL
Phillips	NULL
AF	NULL
,	NULL
Samelson	NULL
LE	NULL
:	NULL
Inhibition	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
prevents	NULL
T-cell	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:7722	NULL
,	NULL
1990	NULL
12	NULL
.	NULL

Lane	NULL
PJL	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
McConnell	NULL
FM	NULL
,	NULL
Draves	NULL
K	NULL
,	NULL
Deans	NULL
J	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Clark	NULL
EA	NULL
:	NULL
The	NULL
role	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
signal	NULL
transduction	NULL
through	NULL
surface	NULL
Ig	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
146:715	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Siegel	NULL
JN	NULL
,	NULL
Egerton	NULL
M	NULL
,	NULL
Phillips	NULL
AF	NULL
,	NULL
Samelson	NULL
LE	NULL
:	NULL
Multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
through	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
for	NULL
antigen	NULL
.	NULL

Semin	NULL
Immunol	NULL
3:325	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Burkhardt	NULL
AL	NULL
,	NULL
Brunswick	NULL
M	NULL
,	NULL
Bolen	NULL
JB	NULL
,	NULL
Mond	NULL
JJ	NULL
:	NULL
Anti-im-munoglobulin	NULL
stimulation	NULL
of	NULL
B	NULL
lymphocytes	NULL
activates	NULL
src-related	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:7410	NULL
,	NULL
1991	NULL
15	NULL
.	NULL

Uckun	NULL
FM	NULL
,	NULL
Tuel-Ahlgren	NULL
L	NULL
,	NULL
Song	NULL
CW	NULL
,	NULL
Waddick	NULL
K	NULL
,	NULL
Myers	NULL
DE	NULL
,	NULL
Kirihara	NULL
J	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Schieven	NULL
GL	NULL
:	NULL
Ionizing	NULL
radiation	NULL
stimulates	NULL
unidentified	NULL
tyrosine-specific	NULL
protein	NULL
kinases	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
triggering	NULL
apoptosis	NULL
and	NULL
clonogenic	NULL
cell	NULL
death	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:9005	NULL
,	NULL
1992	NULL
16	NULL
.	NULL

Uckun	NULL
FM	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Tuel-Ahigren	NULL
LM	NULL
,	NULL
Dibirdik	NULL
I	NULL
,	NULL
Myers	NULL
DE	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Song	NULL
CW	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
is	NULL
a	NULL
mandatory	NULL
proximal	NULL
step	NULL
in	NULL
radiation-induced	NULL
activation	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
signaling	NULL
pathway	NULL
in	NULL
human	NULL
B-lymphocyte	NULL
precursors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:252	NULL
,	NULL
1993	NULL
17	NULL
.	NULL

Gilliland	NULL
LK	NULL
,	NULL
Grossmann	NULL
A	NULL
,	NULL
Rabiovitch	NULL
PS	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
Composite	NULL
signal	NULL
transduction	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
:	NULL
Enhancement	NULL
,	NULL
inhibition	NULL
,	NULL
and	NULL
desensitization	NULL
,	NULL
in	NULL
Cambier	NULL
JC	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Ligands	NULL
,	NULL
Receptors	NULL
and	NULL
Signal	NULL
Transduction	NULL
in	NULL
Regulation	NULL
of	NULL
Lymphocyte	NULL
Function	NULL
.	NULL

Washington	NULL
,	NULL
DC	NULL
,	NULL
American	NULL
Society	NULL
of	NULL
Microbiology	NULL
,	NULL
1993	NULL
,	NULL
p	NULL
321	NULL
18	NULL
.	NULL

Uckun	NULL
FM	NULL
,	NULL
Mitchell	NULL
JB	NULL
,	NULL
Obuz	NULL
V	NULL
,	NULL
Park	NULL
CH	NULL
,	NULL
Waddick	NULL
K	NULL
,	NULL
Friedman	NULL
N	NULL
,	NULL
Oubaha	NULL
L	NULL
,	NULL
Min	NULL
WS	NULL
,	NULL
Song	NULL
CW	NULL
:	NULL
Radiation	NULL
sensitivity	NULL
of	NULL
human	NULL
B-lineage	NULL
lymphoid	NULL
precursor	NULL
cells	NULL
.	NULL

Int	NULL
J	NULL
Radiat	NULL
Oncol	NULL
Biol	NULL
Phys	NULL
21:1	NULL
553	NULL
,	NULL
1991	NULL
19	NULL
.	NULL

Uckun	NULL
FM	NULL
,	NULL
Gillis	NULL
S	NULL
,	NULL
Souza	NULL
L	NULL
,	NULL
Song	NULL
CW	NULL
:	NULL
Effects	NULL
of	NULL
recombi-nant	NULL
growth	NULL
factors	NULL
on	NULL
radiation	NULL
survival	NULL
of	NULL
human	NULL
bone	NULL
marrow	NULL
progenitor	NULL
cells	NULL
.	NULL

Int	NULL
J	NULL
Radiat	NULL
Oncol	NULL
Biol	NULL
Phys	NULL
16:415	NULL
,	NULL
1989	NULL
20	NULL
.	NULL

Uckun	NULL
FM	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Dibirdik	NULL
I	NULL
,	NULL
Chandan-Langlie	NULL
M	NULL
,	NULL
Tuel-Ahigren	NULL
L	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
Stimulation	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
phosphoinositide	NULL
turnover	NULL
,	NULL
and	NULL
multiple	NULL
previ-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1220	NULL
ously	NULL
unidentified	NULL
serine/threonine-specific	NULL
protein	NULL
kinases	NULL
by	NULL
the	NULL
pan-B-cell	NULL
receptor	NULL
CD40/Bp50	NULL
at	NULL
discrete	NULL
developmental	NULL
stages	NULL
of	NULL
human	NULL
B-cell	NULL
ontogeny	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:17478	NULL
,	NULL
1991	NULL
21	NULL
.	NULL

Dignam	NULL
JD	NULL
,	NULL
Lebovitz	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
11:1475	NULL
,	NULL
1983	NULL
22	NULL
.	NULL

Osborn	NULL
L	NULL
,	NULL
Kunkel	NULL
S	NULL
,	NULL
Nabel	NULL
GJ	NULL
:	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
8§6:2336	NULL
,	NULL
1989	NULL
23	NULL
.	NULL

Singh	NULL
H	NULL
,	NULL
Sen	NULL
R	NULL
,	NULL
Baltimore	NULL
D	NULL
,	NULL
Sharp	NULL
PA	NULL
:	NULL
A	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
conserved	NULL
sequence	NULL
motif	NULL
in	NULL
transcriptional	NULL
control	NULL
elements	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
319:154	NULL
,	NULL
1986	NULL
24	NULL
.	NULL

Kanner	NULL
SB	NULL
,	NULL
Damle	NULL
NK	NULL
,	NULL
Blake	NULL
J	NULL
,	NULL
Aruffo	NULL
A	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
CD2/LFA3	NULL
ligation	NULL
induces	NULL
phospholipase	NULL
Cy	NULL
1	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
regulates	NULL
CD3	NULL
signaling	NULL
.	NULL

J	NULL
Immunol	NULL
148:2023	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Sancho	NULL
J	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Choi	NULL
MS	NULL
,	NULL
Kanner	NULL
SB	NULL
,	NULL
Deans	NULL
JP	NULL
,	NULL
Terhorst	NULL
C	NULL
:	NULL
CD3-	NULL
{	NULL
surface	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
CD4-p56	NULL
``	NULL
-mediated	NULL
up-regulation	NULL
of	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-CD3	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:7871	NULL
,	NULL
1992	NULL
26	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Sefton	NULL
BM	NULL
:	NULL
Identification	NULL
of	NULL
multiple	NULL
novel	NULL
polypeptide	NULL
substrates	NULL
of	NULL
the	NULL
v-src	NULL
,	NULL
v-yes	NULL
,	NULL
v-fps	NULL
,	NULL
v-ros	NULL
,	NULL
and	NULL
v-erb-B	NULL
oncogenic	NULL
tyrosine	NULL
protein	NULL
kinases	NULL
utilizing	NULL
antisera	NULL
against	NULL
phos-photyrosine	NULL
.	NULL

Oncogene	NULL
2:305	NULL
,	NULL
1988	NULL
27	NULL
.	NULL

Schieven	NULL
GL	NULL
,	NULL
Kallestad	NULL
JC	NULL
,	NULL
Brown	NULL
TJ	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Linsley	NULL
PS	NULL
:	NULL
Oncostatin	NULL
M	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
endothelial	NULL
cells	NULL
and	NULL
activation	NULL
of	NULL
p62	NULL
``	NULL
tyrosine	NULL
kinase	NULL
.	NULL

J	NULL
Immunol	NULL
149:1676	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Eisenman	NULL
E	NULL
,	NULL
Bolen	NULL
JB	NULL
:	NULL
Src-related	NULL
tyrosine	NULL
protein	NULL
kinases	NULL
as	NULL
signaling	NULL
components	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Cancer	NULL
Cells	NULL
2:303	NULL
,	NULL
1990	NULL
29	NULL
.	NULL

Rabinovitch	NULL
PS	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Grossman	NULL
A	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
Heterogeneity	NULL
among	NULL
T	NULL
cells	NULL
in	NULL
intracellular	NULL
free	NULL
calcium	NULL
response	NULL
after	NULL
mitogen	NULL
stimulation	NULL
with	NULL
PHA	NULL
or	NULL
anti-CD3	NULL
.	NULL

Simultaneous	NULL
use	NULL
of	NULL
indo-1	NULL
and	NULL
immunofluorescence	NULL
with	NULL
flow	NULL
cytometry	NULL
.	NULL

J	NULL
Immunol	NULL
137:952	NULL
,	NULL
1986	NULL
30	NULL
.	NULL

Uckun	NULL
FM	NULL
,	NULL
Dibirdik	NULL
I	NULL
,	NULL
Smith	NULL
R	NULL
,	NULL
Tuel-Ahigren	NULL
L	NULL
,	NULL
Chandan-Langlie	NULL
M	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Waddick	NULL
KG	NULL
,	NULL
Hanson	NULL
M	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
Interleukin	NULL
7	NULL
receptor	NULL
ligation	NULL
stimulates	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
inositol	NULL
phopholipid	NULL
turnover	NULL
,	NULL
and	NULL
clonal	NULL
proliferation	NULL
of	NULL
human	NULL
B-cell	NULL
precursors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:3589	NULL
,	NULL
1991	NULL
31	NULL
.	NULL

Zick	NULL
Y	NULL
,	NULL
Sagi-Eisenberg	NULL
R	NULL
:	NULL
A	NULL
combination	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
concomitantly	NULL
stimulates	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
polyphosphoinositide	NULL
breakdown	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

Biochemistry	NULL
29:10240	NULL
,	NULL
1990	NULL
32	NULL
.	NULL

Heffetz	NULL
D	NULL
,	NULL
Bushkin	NULL
I	NULL
,	NULL
Dror	NULL
R	NULL
,	NULL
Zick	NULL
Y	NULL
:	NULL
The	NULL
insulinomimetic	NULL
agents	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
vanadate	NULL
stimulate	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:2896	NULL
,	NULL
1990	NULL
33	NULL
.	NULL

O'Shea	NULL
JJ	NULL
,	NULL
McVicar	NULL
DW	NULL
,	NULL
Bailey	NULL
TL	NULL
,	NULL
Burns	NULL
C	NULL
,	NULL
Smyth	NULL
MJ	NULL
:	NULL
Activation	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
by	NULL
pharmaco-logical	NULL
induction	NULL
of	NULL
protein-tyrosine	NULL
phosphorylation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:10306	NULL
,	NULL
1992	NULL
34	NULL
.	NULL

Gilliland	NULL
LK	NULL
,	NULL
Schieven	NULL
GL	NULL
,	NULL
Norris	NULL
N	NULL
,	NULL
Kanner	NULL
SB	NULL
,	NULL
Aruffo	NULL
A	NULL
,	NULL
Ledbetter	NULL
JA	NULL
:	NULL
Lymphocyte	NULL
lineage-restricted	NULL
tyrosine-phosphory-lated	NULL
proteins	NULL
that	NULL
bind	NULL
PLCy1	NULL
SH2	NULL
domains	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:13610	NULL
,	NULL
1992	NULL
35	NULL
.	NULL

Settleman	NULL
J	NULL
,	NULL
Narasimhan	NULL
V	NULL
,	NULL
Foster	NULL
LC	NULL
,	NULL
Weinberg	NULL
RA	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
cDNAs	NULL
encoding	NULL
the	NULL
GAP-associated	NULL
protein	NULL
SCHIEVEN	NULL
ET	NULL
AL	NULL
p190	NULL
;	NULL
Implications	NULL
for	NULL
a	NULL
signaling	NULL
pathway	NULL
from	NULL
ras	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Cell	NULL
69:539	NULL
,	NULL
1992	NULL
36	NULL
.	NULL

Wong	NULL
G	NULL
,	NULL
Muller	NULL
0	NULL
,	NULL
Clark	NULL
R	NULL
,	NULL
Conroy	NULL
L	NULL
,	NULL
Moran	NULL
MF	NULL
,	NULL
Polakis	NULL
P	NULL
,	NULL
McCormick	NULL
F	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
nucleic	NULL
acid	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
GAP-associated	NULL
tyrosine	NULL
phosphoprotein	NULL
p62	NULL
.	NULL

Cell	NULL
69:551	NULL
,	NULL
1992	NULL
37	NULL
.	NULL

Marth	NULL
JD	NULL
,	NULL
Lewis	NULL
DB	NULL
,	NULL
Cooke	NULL
MP	NULL
,	NULL
Mellins	NULL
ED	NULL
,	NULL
Gearn	NULL
ME	NULL
,	NULL
Samelson	NULL
LE	NULL
,	NULL
Wilson	NULL
CB	NULL
,	NULL
Miller	NULL
AD	NULL
,	NULL
Perlmutter	NULL
RD	NULL
:	NULL
Lymphocyte	NULL
activation	NULL
provokes	NULL
modification	NULL
of	NULL
a	NULL
Iymphocyte-specific	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
p56	NULL
``	NULL
**	NULL
)	NULL
.	NULL

J	NULL
Immunol	NULL
142:2430	NULL
,	NULL
1989	NULL
38	NULL
.	NULL

Iwasaki	NULL
T	NULL
,	NULL
Uehara	NULL
Y	NULL
,	NULL
Graves	NULL
L	NULL
,	NULL
Rachie	NULL
N	NULL
,	NULL
Bomsztyk	NULL
K	NULL
:	NULL
Herbimycin	NULL
A	NULL
blocks	NULL
IL-1-induced	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

FEBS	NULL
Lett	NULL
298:240	NULL
,	NULL
1992	NULL
39	NULL
.	NULL

Devary	NULL
Y	NULL
,	NULL
Gottlieb	NULL
RA	NULL
,	NULL
Smeal	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
The	NULL
mammalian	NULL
ultraviolet	NULL
response	NULL
is	NULL
triggered	NULL
by	NULL
activation	NULL
of	NULL
src	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Cell	NULL
71:1081	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Kuwabara	NULL
M	NULL
,	NULL
Inanami	NULL
O	NULL
,	NULL
Endoh	NULL
D	NULL
,	NULL
Sato	NULL
F	NULL
:	NULL
Spin	NULL
trapping	NULL
of	NULL
precursors	NULL
of	NULL
thymine	NULL
damage	NULL
in	NULL
X-irradiated	NULL
DNA	NULL
.	NULL

Biochemistry	NULL
26:2458	NULL
,	NULL
1987	NULL
41	NULL
.	NULL

Hunter	NULL
T	NULL
:	NULL
Protein-tyrosine	NULL
phosphatases	NULL
:	NULL
The	NULL
other	NULL
side	NULL
of	NULL
the	NULL
coin	NULL
.	NULL

Cell	NULL
58:435	NULL
,	NULL
1989	NULL
42	NULL
.	NULL

Kadota	NULL
S	NULL
,	NULL
Fantus	NULL
IG	NULL
,	NULL
Deragon	NULL
G	NULL
,	NULL
Guyda	NULL
HJ	NULL
,	NULL
Hersh	NULL
B	NULL
,	NULL
Posner	NULL
B	NULL
:	NULL
Peroxide	NULL
(	NULL
s	NULL
)	NULL
of	NULL
vanadium	NULL
:	NULL
A	NULL
novel	NULL
and	NULL
potent	NULL
insulin-mi-metic	NULL
agent	NULL
which	NULL
activates	NULL
the	NULL
insulin	NULL
receptor	NULL
kinase	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
147:259	NULL
,	NULL
1987	NULL
43	NULL
.	NULL

Fantus	NULL
IG	NULL
,	NULL
Kadota	NULL
S	NULL
,	NULL
Deragon	NULL
G	NULL
,	NULL
Foster	NULL
B	NULL
,	NULL
Posner	NULL
B	NULL
:	NULL
Per-vanadate	NULL
[	NULL
peroxide	NULL
(	NULL
s	NULL
)	NULL
of	NULL
vanadate	NULL
]	NULL
mimics	NULL
insulin	NULL
action	NULL
in	NULL
rat	NULL
adi-pocytes	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
insulin	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Biochemistry	NULL
28:8864	NULL
,	NULL
1989	NULL
44	NULL
.	NULL

Garcia-Morales	NULL
P	NULL
,	NULL
Minami	NULL
Y	NULL
,	NULL
Luong	NULL
E	NULL
,	NULL
Klausner	NULL
RD	NULL
,	NULL
Samelson	NULL
LE	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
phosphatase	NULL
activity	NULL
:	NULL
Studies	NULL
with	NULL
phenylarsine	NULL
oxide	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
§7:9255	NULL
,	NULL
1990	NULL
45	NULL
.	NULL

Koretzky	NULL
GA	NULL
,	NULL
Picus	NULL
J	NULL
,	NULL
Schultz	NULL
T	NULL
,	NULL
Weiss	NULL
A	NULL
:	NULL
Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
and	NULL
CD2-mediated	NULL
activation	NULL
of	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:2037	NULL
,	NULL
1991	NULL
46	NULL
.	NULL

Smythe	NULL
C	NULL
,	NULL
Newport	NULL
JW	NULL
:	NULL
Coupling	NULL
of	NULL
mitosis	NULL
to	NULL
the	NULL
completion	NULL
of	NULL
S	NULL
phase	NULL
in	NULL
Xenopus	NULL
occurs	NULL
via	NULL
modulation	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
that	NULL
phosphorylates	NULL
p34	NULL
.	NULL

Cell	NULL
68:787	NULL
,	NULL
1992	NULL
47	NULL
.	NULL

Davis	NULL
LS	NULL
,	NULL
Wacholtz	NULL
MC	NULL
,	NULL
Lipsky	NULL
PE	NULL
:	NULL
The	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
by	NULL
rapidly	NULL
modulating	NULL
CD3	NULL
.	NULL

J	NULL
Immunol	NULL
142:1084	NULL
,	NULL
1989	NULL
48	NULL
.	NULL

Jenkins	NULL
MK	NULL
,	NULL
Pardoll	NULL
DM	NULL
,	NULL
Miuguchi	NULL
J	NULL
,	NULL
Chused	NULL
TM	NULL
,	NULL
Schwartz	NULL
RM	NULL
:	NULL
Molecular	NULL
events	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
nonrespon-sive	NULL
state	NULL
in	NULL
interleukin	NULL
2-producing	NULL
helper	NULL
T-lymphocyte	NULL
clones	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
$	NULL
4:5409	NULL
,	NULL
1987	NULL
49	NULL
.	NULL

Greaves	NULL
MF	NULL
:	NULL
Models	NULL
of	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Leukemia	NULL
5:819	NULL
,	NULL
1991	NULL
50	NULL
.	NULL

Cerutti	NULL
PA	NULL
:	NULL
Prooxidant	NULL
states	NULL
and	NULL
tumor	NULL
promotion	NULL
.	NULL

Science	NULL
227:375	NULL
,	NULL
1985	NULL
51	NULL
.	NULL

Roederer	NULL
M	NULL
,	NULL
Staal	NULL
FJ	NULL
,	NULL
Raju	NULL
PA	NULL
,	NULL
Ela	NULL
SW	NULL
,	NULL
Herzenberg	NULL
LA	NULL
,	NULL
Herzenberg	NULL
L	NULL
:	NULL
Cytokine-stimulated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
is	NULL
inhibited	NULL
by	NULL
N-acetyl-L-cysteine	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:4884	NULL
,	NULL
1990	NULL
52	NULL
.	NULL

Staal	NULL
FJ	NULL
,	NULL
Roederer	NULL
M	NULL
,	NULL
Herzenberg	NULL
LA	NULL
:	NULL
Intracellular	NULL
thiols	NULL
regulate	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:9943	NULL
,	NULL
1990	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1993	NULL
82	NULL
:	NULL
1212-1220	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
activate	NULL
NF-kappa	NULL
B	NULL
in	NULL
a	NULL
tyrosine	NULL
kinase-	NULL
dependent	NULL
mechanism	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
vanadate	NULL
activate	NULL
the	NULL
p56lck	NULL
and	NULL
p59fyn	NULL
tyrosine	NULL
kinases	NULL
in	NULL
human	NULL
lymphocytes	NULL
GL	NULL
Schieven	NULL
,	NULL
JM	NULL
Kirihara	NULL
,	NULL
DE	NULL
Myers	NULL
,	NULL
JA	NULL
Ledbetter	NULL
and	NULL
FM	NULL
Uckun	NULL
o	NULL
)	NULL
A	NULL
A	NULL
~	NULL
0	NULL
%	NULL
A	NULL
(	NULL
peRICAy	NULL
,	NULL
?	NULL

_	NULL
‘	NULL
\	NULL
“	NULL
do	NULL
,	NULL
'	NULL
c	NULL
Alf	NULL
“	NULL
)	NULL
.	NULL

«	NULL
3	NULL
®	NULL
~Q1o	NULL
%	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/82/4/1212.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

